<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">55589</article-id><article-id pub-id-type="doi">10.7554/eLife.55589</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Apelin signaling drives vascular endothelial cells toward a pro-angiogenic state</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-174826"><name><surname>Helker</surname><given-names>Christian SM</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0427-5338</contrib-id><email>christian.helker@biologie.uni-marburg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174827"><name><surname>Eberlein</surname><given-names>Jean</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174828"><name><surname>Wilhelm</surname><given-names>Kerstin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174829"><name><surname>Sugino</surname><given-names>Toshiya</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6330-7275</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-205982"><name><surname>Malchow</surname><given-names>Julian</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28585"><name><surname>Schuermann</surname><given-names>Annika</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174830"><name><surname>Baumeister</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174831"><name><surname>Kwon</surname><given-names>Hyouk-Bum</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20399"><name><surname>Maischein</surname><given-names>Hans-Martin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80708"><name><surname>Potente</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28001"><name><surname>Herzog</surname><given-names>Wiebke</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-7189"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0382-0026</contrib-id><email>Didier.Stainier@mpi-bn.mpg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research</institution><addr-line><named-content content-type="city">Bad Nauheim</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution>Philipps-University Marburg, Faculty of Biology, Cell Signaling and Dynamics</institution><addr-line><named-content content-type="city">Marburg</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution>Angiogenesis and Metabolism Laboratory, Max Planck Institute for Heart and Lung Research</institution><addr-line><named-content content-type="city">Bad Nauheim</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution>University of Muenster</institution><addr-line><named-content content-type="city">Muenster</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution>DZHK (German Center for Cardiovascular Research), partner site Frankfurt Rhine-Main</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff6"><label>6</label><institution>Max Planck Institute for Molecular Biomedicine</institution><addr-line><named-content content-type="city">Muenster</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Burns</surname><given-names>Caroline E</given-names></name><role>Reviewing Editor</role><aff><institution>Boston Children's Hospital</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution>California Institute of Technology</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>21</day><month>09</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e55589</elocation-id><history><date date-type="received" iso-8601-date="2020-01-29"><day>29</day><month>01</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-09-19"><day>19</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Helker et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Helker et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-55589-v2.pdf"/><abstract><p>To form new blood vessels (angiogenesis), endothelial cells (ECs) must be activated and acquire highly migratory and proliferative phenotypes. However, the molecular mechanisms that govern these processes are incompletely understood. Here, we show that Apelin signaling functions to drive ECs into such an angiogenic state. Zebrafish lacking Apelin signaling exhibit defects in endothelial tip cell morphology and sprouting. Using transplantation experiments, we find that in mosaic vessels, wild-type ECs leave the dorsal aorta (DA) and form new vessels while neighboring ECs defective in Apelin signaling remain in the DA. Mechanistically, Apelin signaling enhances glycolytic activity in ECs at least in part by increasing levels of the growth-promoting transcription factor c-Myc. Moreover, <italic>APELIN</italic> expression is regulated by Notch signaling in human ECs, and its function is required for the hypersprouting phenotype in Delta-like 4 (Dll4) knockdown zebrafish embryos. These data provide new insights into fundamental principles of blood vessel formation and Apelin signaling, enabling a better understanding of vascular growth in health and disease.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>apelin</kwd><kwd>notch</kwd><kwd>metabolism</kwd><kwd>angiogenesis</kwd><kwd>endothelial cells</kwd><kwd>sprouting</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB 834</award-id><principal-award-recipient><name><surname>Helker</surname><given-names>Christian SM</given-names></name><name><surname>Stainier</surname><given-names>Didier YR</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>GRK2213</award-id><principal-award-recipient><name><surname>Helker</surname><given-names>Christian SM</given-names></name><name><surname>Eberlein</surname><given-names>Jean</given-names></name><name><surname>Malchow</surname><given-names>Julian</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>HE4585/3-1</award-id><principal-award-recipient><name><surname>Herzog</surname><given-names>Wiebke</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010663</institution-id><institution>H2020 European Research Council</institution></institution-wrap></funding-source><award-id>EMERGE (773047)</award-id><principal-award-recipient><name><surname>Potente</surname><given-names>Michael</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>EXC 2026</award-id><principal-award-recipient><name><surname>Potente</surname><given-names>Michael</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010663</institution-id><institution>H2020 European Research Council</institution></institution-wrap></funding-source><award-id>AdG project: ZMOD 694455</award-id><principal-award-recipient><name><surname>Stainier</surname><given-names>Didier YR</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>North Rhine-Westphalia</institution></institution-wrap></funding-source><award-id>Return fellowship</award-id><principal-award-recipient><name><surname>Herzog</surname><given-names>Wiebke</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004189</institution-id><institution>Max-Planck-Gesellschaft</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Helker</surname><given-names>Christian SM</given-names></name><name><surname>Wilhelm</surname><given-names>Kerstin</given-names></name><name><surname>Sugino</surname><given-names>Toshiya</given-names></name><name><surname>Kwon</surname><given-names>Hyouk-Bum</given-names></name><name><surname>Maischein</surname><given-names>Hans-Martin</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Apelin signaling promotes sprouting behavior of endothelial cells by modulating their metabolic state.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Endothelial cell sprouting is a fundamental process of physiological and pathological blood vessel growth. Attracted by growth factors such as vascular endothelial growth factor-A (VEGF-A) secreted from hypoxic tissues, endothelial cells (ECs) break out of the quiescent vessel wall to form new vessel branches (<xref ref-type="bibr" rid="bib18">Ferrara et al., 2003</xref>; <xref ref-type="bibr" rid="bib39">Koch and Claesson-Welsh, 2012</xref>). ECs with higher levels of VEGF-A signaling become invasive tip cells that lead new vascular sprouts, while neighboring ECs with lower VEGF-A signaling become trailing stalk cells (<xref ref-type="bibr" rid="bib19">Gerhardt et al., 2003</xref>). This process is coordinated by Delta-like 4 (DLL4)/Notch signaling. Activation of Notch receptors by their ligand DLL4, expressed by tip cells, represses tip cell behavior in stalk cells (<xref ref-type="bibr" rid="bib28">HellstrÃ¶m et al., 2007</xref>; <xref ref-type="bibr" rid="bib44">Leslie et al., 2007</xref>; <xref ref-type="bibr" rid="bib58">Siekmann and Lawson, 2007</xref>; <xref ref-type="bibr" rid="bib59">Suchting et al., 2007</xref>). Loss of Notch signaling, on the other hand, causes excessive tip cell formation and vascular overgrowth (<xref ref-type="bibr" rid="bib28">HellstrÃ¶m et al., 2007</xref>; <xref ref-type="bibr" rid="bib44">Leslie et al., 2007</xref>; <xref ref-type="bibr" rid="bib58">Siekmann and Lawson, 2007</xref>; <xref ref-type="bibr" rid="bib59">Suchting et al., 2007</xref>).</p><p>Apelin (Apln) is a small secreted peptide, which was initially identified because of its inotropic activity (<xref ref-type="bibr" rid="bib60">Szokodi et al., 2002</xref>). <italic>Apelin</italic> was subsequently described as a tip cell-enriched gene (<xref ref-type="bibr" rid="bib15">del Toro et al., 2010</xref>). Apelin (<xref ref-type="bibr" rid="bib62">Tatemoto et al., 1998</xref>), as well as the newly identified ligand Apela (<xref ref-type="bibr" rid="bib8">Chng et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Pauli et al., 2014</xref>), can both activate the Apelin receptor (Aplnr), a 7-transmembrane G-protein-coupled receptor (GPCR). Mouse and frog embryos lacking Apln or Aplnr function exhibit reduced vascular outgrowth, decreased EC proliferation, smaller vessel diameter as well as defects in the alignment of arteries and veins (<xref ref-type="bibr" rid="bib11">Cox et al., 2006</xref>; <xref ref-type="bibr" rid="bib33">KÃ¤lin et al., 2007</xref>; <xref ref-type="bibr" rid="bib34">Kidoya et al., 2008</xref>; <xref ref-type="bibr" rid="bib15">del Toro et al., 2010</xref>; <xref ref-type="bibr" rid="bib35">Kidoya et al., 2010</xref>; <xref ref-type="bibr" rid="bib37">Kidoya et al., 2015</xref>; <xref ref-type="bibr" rid="bib49">Papangeli et al., 2016</xref>). In addition, Apelin signaling has been implicated in several cardiovascular diseases including pulmonary hypertension (<xref ref-type="bibr" rid="bib20">Goetze et al., 2006</xref>; <xref ref-type="bibr" rid="bib1">Alastalo et al., 2011</xref>; <xref ref-type="bibr" rid="bib5">Chandra et al., 2011</xref>), atherosclerosis (<xref ref-type="bibr" rid="bib24">Hashimoto et al., 2007</xref>; <xref ref-type="bibr" rid="bib10">Chun et al., 2008</xref>; <xref ref-type="bibr" rid="bib40">Kojima et al., 2010</xref>; <xref ref-type="bibr" rid="bib52">Pitkin et al., 2010</xref>), myocardial infarction (<xref ref-type="bibr" rid="bib63">Tempel et al., 2012</xref>; <xref ref-type="bibr" rid="bib70">Wang et al., 2013</xref>; <xref ref-type="bibr" rid="bib73">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib6">Chen et al., 2017</xref>), and tumor angiogenesis (<xref ref-type="bibr" rid="bib36">Kidoya et al., 2012</xref>; <xref ref-type="bibr" rid="bib74">Zhao et al., 2018</xref>; <xref ref-type="bibr" rid="bib66">Uribesalgo et al., 2019</xref>). However, the cellular mechanisms by which Apelin signaling functions within the vasculature remain elusive. Using zebrafish mutants combined with mosaic analyses, high-resolution time-lapse imaging, and metabolic studies, we find that Apelin signaling is required to boost endothelial metabolic activity during angiogenic sprouting. Furthermore, we show that Apelin signaling acts downstream of Notch signaling, where it is required for Notch-controlled angiogenesis.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Apelin signaling is required for angiogenic sprouting</title><p>To examine the expression pattern of the <italic>apelin</italic> ligand and receptor genes during angiogenic sprouting in zebrafish embryos, we first performed whole-mount in situ hybridization during intersegmental vessel (ISV) formation. We detected clear <italic>alpn</italic>, but no <italic>apela</italic>, expression within the sprouting ISVs (<xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1</xref> arrowheads). For the receptor genes, we could only detect <italic>aplnrb</italic> expression in the ISVs (<xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1</xref> arrowheads).</p><p>To visualize <italic>apln</italic> and <italic>aplnrb</italic> expression at single cell resolution, we developed reporters using Bacterial artificial chromosome (BAC) recombineering (<xref ref-type="fig" rid="fig1s2">Figure 1âfigure supplement 2</xref>). To this end, we replaced the ATG of an <italic>apln</italic> containing BAC with an EGFP cassette. Similarly, we replaced the stop codon of an <italic>aplnrb</italic> containing BAC with a tandem fluorescent timer (TagRFP-sfGFP) cassette leading to a fusion protein. We injected both modified BACs into one-cell stage zebrafish embryos to generate stable transgenic lines, <italic>Tg(apln:EGFP)</italic> and <italic>Tg(aplnrb:aplnrb-TagRFP-sfGFP)</italic> (hereafter referred to <italic>Tg(aplnrb:aplnrb-sfGFP)</italic>) (<xref ref-type="fig" rid="fig1s2">Figure 1âfigure supplement 2</xref>). We first detected weak <italic>apln</italic>:EGFP expression in sprouting ISVs at 30 hpf (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). At 54 hpf, all ECs within the dorsal longitudinal anastomotic vessel (DLAV) â a vessel formed by tip cells â were labeled (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, arrowheads) while some stalk cells also exhibited weak <italic>apln</italic>:GFP expression (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, arrows). Of note, <italic>aplnrb</italic>:Aplrnb-sfGFP expression at 26 hpf was visible in the entire ISV sprout (<xref ref-type="fig" rid="fig1">Figure 1B</xref> arrowheads), but it was absent from non-angiogenic ECs within the dorsal aorta (DA). At 54 hpf, <italic>aplnrb</italic>:Aplrnb-sfGFP expression was detected in all ECs that had sprouted out of the DA but also weakly in ECs within the DA (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). These results suggest that <italic>apln</italic> is expressed in tip cells while <italic>aplnrb</italic> is expressed in all sprouting ECs.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Apelin signaling promotes endothelial sprouting.</title><p>Visualization of <italic>apelin</italic> and <italic>apelin receptor b</italic> expression using transgenic reporter lines. Confocal projection images of the trunk region of zebrafish embryos. (<bold>A</bold>) <italic>Tg<sup>BAC</sup>(apln:</italic>EGFP) expression is detectable in growing ISVs at 30 and 54 hpf. Arrowheads point to strong <italic>apln</italic> expression in tip cells, while arrows point to weak <italic>apln</italic> expression in stalk cells. (<bold>B</bold>) <italic>Tg<sup>BAC</sup>(aplnrb:</italic>aplnrb-EGFP) expression is detectable in sprouting ECs (arrowheads) at 26 hpf and is clearly present in the ISVs and DLAV at 54 hpf. (<bold>C</bold>) Inactivation of Apelin ligand and receptor genes impairs angiogenesis. Confocal projection images of the blood vasculature in the trunk region of <italic>Tg(fli1a:EGFP)</italic> embryos. <italic>apln <sup>-/-</sup>; apela <sup>-/-</sup></italic> as well as <italic>aplnra <sup>-/-</sup>; aplnrb <sup>-/-</sup></italic> embryos exhibit a reduction in vascular sprouting at 28 and 54 hpf. Arrowheads point to stalled ISVs. Scale bars: Aâ, 10 Âµm; Aââ, Bâ, Câ, Cââ, 20 Âµm; Bââ, 15 Âµm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 1.</label><caption><title>Expression of apelin ligand and receptor genes by in situ hybridization.</title><p>Expression of apelin ligand and receptor genes at 24 and 32 hpf.<italic>Â apln</italic> is expressed in ISVs (arrowheads). <italic>apela</italic> is not detected in blood vessels. <italic>aplnra</italic> is expressed in the posterior cardinal vein. <italic>aplnrb</italic> is expressed in the posterior cardinal vein and ISVs (arrowheads). Scale bars: 500 Âµm; insets, 100 Âµm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 2.</label><caption><title>Generation of the <italic>Tg<sup>BAC</sup>(apln:EGFP) and Tg(aplnrb:aplnrb-TagRFP-sfGFP)</italic> reporter lines.</title><p>BAC engineering was used to generate the <italic>apln:EGFP</italic> and <italic>aplnrb:aplnrb-TagRFP-sfGFP constructs</italic>. The clone RP71-2G21 was engineered to replace the ATG of <italic>apln</italic> with an EGFP cassette. The clone CH211-102K8 was engineered to replace the stop codon of <italic>aplnrb</italic> with a TagRFP-sfGFP cassette. To enhance the frequency of insertion into the genome, <italic>tol2</italic> arms were added to the backbone of the BAC.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 3.</label><caption><title>Quantification of angiogenic defects.</title><p>Confocal projection images of the trunk region of <italic>Tg(fli1a:EGFP)</italic> embryos at 30 hpf. Analysis of the offspring of <italic>apln <sup>+/-</sup>; apela<sup>+/-</sup></italic> (nÂ =Â 85) and <italic>aplnra <sup>+/-</sup>; aplnrb <sup>+/-</sup></italic> (nÂ =Â 71) fish resulted in different phenotypic categories according to the extent of ISV development. Genotyping of single embryos revealed an additive effect for <italic>apln</italic> an<italic>d apela</italic> ligands and <italic>aplnra</italic> and <italic>aplnrb</italic> receptors. Mild phenotypes correlated with loss of single ligand or receptor genes, while deficiency in <italic>apln</italic> resulted in stronger phenotypes than deficiency in <italic>apela. aplnrb</italic> deficiency resulted in stronger phenotypes than deficiency in <italic>aplnra</italic>. Deficiencies in both ligands or both receptors resulted in more severe phenotypes. Scale bar: 40 Âµm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig1-figsupp3-v2.tif"/></fig></fig-group><p>To examine the function of Apelin signaling during sprouting angiogenesis in zebrafish, we used mutants for <italic>aplnra</italic> (<xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref>)<italic>, aplnrb</italic> (<xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref>)<italic>, apln</italic> (<xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref>) and <italic>apela</italic> (<xref ref-type="bibr" rid="bib8">Chng et al., 2013</xref>). Homozygous <italic>aplnra</italic> mutant embryos exhibited no obvious defects during ISV formation (<xref ref-type="fig" rid="fig1s3">Figure 1âfigure supplement 3</xref>). However, homozygous <italic>aplnrb</italic> mutant embryos exhibited reduced ISV length and failed to form the DLAV (<xref ref-type="fig" rid="fig1s3">Figure 1âfigure supplement 3</xref>). This phenotype was more severe in embryos lacking both <italic>aplnra</italic> and <italic>aplnrb</italic> (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1âfigure supplement 3</xref>), indicating partial compensation. We also analyzed <italic>apln</italic> and <italic>apela</italic> mutants. Homozygous <italic>apela</italic> mutant embryos displayed only a mild delay in ISV outgrowth (<xref ref-type="fig" rid="fig1s3">Figure 1âfigure supplement 3</xref>), while homozygous <italic>apln</italic> mutant embryos exhibited defects in ISV outgrowth and failure to form the DLAV (<xref ref-type="fig" rid="fig1s3">Figure 1âfigure supplement 3</xref>). Loss of both ligands increased the severity of the phenotype leading to ISV stalling at the horizontal myoseptum (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1âfigure supplement 3</xref>). Consistent with studies in the mouse retina (<xref ref-type="bibr" rid="bib15">del Toro et al., 2010</xref>), our studies identify <italic>apln</italic> expression as a marker of endothelial tip cells in zebrafish and show that Apelin signaling is required for angiogenic sprouting.</p></sec><sec id="s2-2"><title>Apelin signaling regulates tip cell morphology</title><p>To investigate when the sprouting defects in Apelin signaling-deficient embryos first appear, we analyzed developmental time points when tip cells start to sprout out of the DA. However, no differences in sprout initiation or tip cell specification were observed in double homozygous receptor or ligand mutants (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2A</xref>). Instead, we found that sprout elongation was slower in these mutant embryos, resulting in an overall reduction of sprout length (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="video" rid="fig2video1">Figure 2âvideo 1</xref>, <xref ref-type="video" rid="fig2video2">Figure 2âvideo 2</xref>). Furthermore, while endothelial tip cells in wild-type embryos formed long filopodia which extended toward the dorsal side of the animal (<xref ref-type="fig" rid="fig2">Figure 2A</xref> I, II, <xref ref-type="video" rid="fig2video1">Figure 2âvideo 1</xref>), <italic>aplnr</italic> mutant embryos (<italic>aplnra+/-; aplnrb -/</italic>-Â and <italic>aplnra -/-; aplnrb -/-</italic>) as well as <italic>aplnrb</italic> morpholino (MO) injected embryos (morphants) displayed a blunted tip cell morphology (<xref ref-type="fig" rid="fig2">Figure 2A</xref> III, 2A IV, 2B, C, <xref ref-type="video" rid="fig2video2">Figure 2âvideo 2</xref>), a phenotype which did not recover over time.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Apelin signaling regulates endothelial filopodia formation and endothelial cell numbers.</title><p>(<bold>A</bold>) Still images from confocal time-lapse movies of vascular development in wild-type and <italic>aplnra <sup>+/-</sup>; aplnrb <sup>-/-</sup></italic> embryos. During sprouting, wild-type tip cells send out filopodia (arrowheads). <italic>aplnra <sup>+/-</sup>; aplnrb <sup>-/-</sup></italic> embryos exhibit smaller sprouts and fail to form filopodia. (<bold>B</bold>) Confocal images of the blood vasculature in 24 hpf <italic>Tg(kdrl:HsHRAS-EGFP)</italic> embryos injected with Ctr MO and <italic>aplnrb</italic> MO. <italic>aplnrb</italic> morphant embryos exhibit smaller sprouts and fail to form filopodia (arrowheads). (<bold>C</bold>) <italic>aplnrb</italic> morphant embryos exhibit a reduction in the number of endothelial filopodia (Ctr MO, nÂ =Â 10; <italic>aplnrb</italic> MO, nÂ =Â 15). (<bold>D</bold>) Confocal images of the blood vasculature of 30 and 52 hpf <italic>Tg(fli1a:nEGFP)</italic> wild-type and <italic>aplnra <sup>+/-</sup>; aplnrb <sup>-/-</sup></italic> embryos showing EC cell nuclei. (<bold>E</bold>) <italic>aplnra <sup>+/-</sup>; aplnrb <sup>-/-</sup></italic> embryos exhibit reduced EC numbers in the ISVs (30 hpf: <italic>aplnr +/+,</italic> nÂ =Â 3; <italic>aplnr +/-,</italic> nÂ =Â 10; <italic>aplnr -/-,</italic> nÂ =Â 8; 52 hpf: <italic>aplnr +/+,</italic> nÂ =Â 5; <italic>aplnr +/-,</italic> nÂ =Â 10; <italic>aplnr -/-,</italic> nÂ =Â 9). n.s. not significant (two-tailed t-test). Scale bars: A, D, 20 Âµm; B, 40 Âµm; B, inset 10 Âµm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 1.</label><caption><title>No obvious defects during initiation of EC sprouting in Apelin signaling-deficient embryos.</title><p>Confocal projection images of the trunk region of <italic>Tg(fli1a:EGFP)</italic> embryos at 21 hpf. Sprouting of ECs from the DA does not appear to be altered in Apelin signaling-deficient embryos. Scale bar: 50 Âµm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 2.</label><caption><title>No obvious defects in EC polarity in Apelin deficient embryos.</title><p>Confocal projection images of the trunk region of <italic>Tg(kdrl:NLS-EGFP); Tg(fli1a:B4GALT1-mCherry)</italic> embryos at 24 hpf. Apelin deficiency does not cause obvious defects in EC polarity (<italic>aplnr +/+,</italic> nÂ =Â 6; <italic>aplnr -/-,</italic> nÂ =Â 8). Arrowheads point to polarized tip cells in the ISVs. Scale bar: 20 Âµm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 3.</label><caption><title>Overexpression of <italic>apln</italic> does not cause ectopic EC sprouting.</title><p>Confocal projection images of the trunk region of <italic>Tg(fli1a:LIFEACT-GFP)</italic> embryos at 23 and 48 hpf. <italic>apln</italic> expression was induced by a single heatshock at 19.5 hpf for 1 hr at 39Â°C and analyzed at 23 hpf or heatshocked at 42 and 45 hpf for 1 hr at 39Â°C and analyzed at 48 hpf. Global overexpression of <italic>apln</italic> does not lead to ectopic vascular sprouting but mispatterning of the string of parachordal lymphangioblasts (arrows).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig2-figsupp3-v2.tif"/></fig><media id="fig2video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-55589-fig2-video1.mp4"><label>Figure 2âvideo 1.</label><caption><title>Confocal time-lapse-imaging of a <italic>Tg(fli1a:EGFP)</italic> wild-type embryo from 23 to 32 hpf.</title><p>During sprouting, wild-type tip cells send out filopodia. Related to <xref ref-type="fig" rid="fig2">Figure 2A</xref>.</p></caption></media><media id="fig2video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-55589-fig2-video2.mp4"><label>Figure 2âvideo 2.</label><caption><title>Confocal time-lapse-imaging of a <italic>Tg(fli1a:EGFP) aplnra <sup>+/-</sup>; aplnrb <sup>-/-</sup></italic> embryos from 23 to 35 hpf.</title><p>During sprouting, <italic>aplnra <sup>+/-</sup>; aplnrb <sup>-/-</sup></italic> embryos exhibit smaller sprouts and fail to form filopodia. Related to <xref ref-type="fig" rid="fig2">Figure 2A</xref>.</p></caption></media></fig-group><p>Previously, we reported a role for Apelin signaling in establishing blood flow-induced EC polarity (<xref ref-type="bibr" rid="bib42">Kwon et al., 2016</xref>). To determine whether the observed defects during sprouting were caused by defects in EC polarity, we analyzed the location of the Golgi apparatus during ISV formation in wild-type and mutant embryos. However, we could not detect obvious differences in EC polarity during angiogenic sprouting (<xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2</xref>, arrowheads point to polarized ECs). Next, we asked whether Apelin signaling regulates the number of ECs, and so combined <italic>aplnr</italic> mutants with the <italic>Tg(fli1a:nEGFP)</italic> reporter line (<xref ref-type="bibr" rid="bib54">Roman et al., 2002</xref>) to visualize EC nuclei. Compared to controls, <italic>aplnr</italic> mutants exhibited a reduction in ISV EC numbers of 1 cell at 30 hpf (4 instead of 5) and 2 cells at 52 hpf (5 instead of 7) (<xref ref-type="fig" rid="fig2">Figure 2D,E</xref>). We next assessed whether <italic>apln</italic> overexpression leads to ectopic sprouting. To this end, we generated an inducible transgenic line to overexpress <italic>apln</italic> under the control of the <italic>hsp70l</italic> promoter. However, global overexpression of <italic>apln</italic> did not lead to ectopic sprouting of blood vessels but led to mispatterned lymphatic vessels (<xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3</xref>, arrows). Altogether, these data indicate that the angiogenic defects in Apelin signaling-deficient embryos are caused by filopodia defects and impaired cell migration. Apelin signaling also regulates the number of ECs within the ISV sprouts.</p></sec><sec id="s2-3"><title>Apelin signaling drives the sprouting behavior of ECs</title><p>We hypothesized that <italic>aplnrb</italic> expression (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) provides an advantage for ECs to sprout. To test this hypothesis, we generated chimeric embryos using wild-type and <italic>aplnr</italic> deficient embryos (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Upon transplantation of wild-type donor cells into wild-type hosts, 34,5% of the donor-derived ECs were present in the ISVs at 24 hpf (<xref ref-type="fig" rid="fig3">Figure 3B,C</xref>). In contrast, upon transplantation of wild-type donor cells into <italic>aplnr-</italic>deficient hosts, 80% of the donor-derived ECs were present in the ISVs at 24 hpf (<xref ref-type="fig" rid="fig3">Figure 3B,C</xref>). Together these data show that the apelin receptors function cell-autonomously in endothelial sprouting. The Apelin receptor has been shown to signal mainly through the G-protein GÎ±i (<xref ref-type="bibr" rid="bib21">Habata et al., 1999</xref>). Therefore, we blocked GÎ±i function through the mosaic and vascular-specific overexpression of pertussis toxin (PTX). Our results show that ECs deficient for signaling though GÎ±i behave similarly to <italic>aplnr</italic> mutant ECs indicating that the Apelin receptor mediates its angiogenic effect through GÎ±i (<xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplement 1</xref>). Notably, wild-type donor-derived ECs in <italic>aplnr</italic> deficient embryos populated the entire dorsal part of the vasculature which is usually missing in these mutants, further confirming the cell-autonomous function of the Apelin receptors during angiogenesis (<xref ref-type="fig" rid="fig3s2">Figure 3âfigure supplement 2</xref>). Together, these results indicate that apelin signaling primes ECs toward a sprouting state.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Apelin signaling promotes the sprouting behavior of ECs.</title><p>(<bold>A</bold>) Experimental design: At the blastula stage, cells from <italic>Tg(kdrl:HsHRAS-mCherry)</italic> embryos were transplanted into host embryos obtained from <italic>Tg(fli1a:EGFP) aplnra <sup>+/-</sup>; aplnrb <sup>+/-</sup></italic> incrosses. At 24 hpf, the mosaic embryos were imaged and the donor-derived ECs scored for their position. (<bold>B, C</bold>) 34,5% of wild-type donor-derived ECs in wild-type hosts were found within the ISVs. 80% of wild-type donor-derived ECs in <italic>aplnra <sup>+/-</sup>; aplnrb <sup>-/-</sup></italic> hosts were found within the ISVs. Notably, wild-type ECs transplanted into <italic>aplnr-</italic> deficient embryos completely substituted for the lack of cells in the dorsal part of the vasculature at 54 hpf (<xref ref-type="fig" rid="fig3s2">Figure 3âfigure supplement 2</xref>). Scale bars: B, 20 Âµm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 1.</label><caption><title>Overexpression of PTX phenocopies loss of Apelin signaling.</title><p>Confocal projection images of the trunk region of <italic>Tg(kdrl:HsHRAS-mCherry)</italic> embryos at 24 hpf. PTX was overexpressed by injecting a bidirectional <italic>fli1a</italic> promoter driving PTX and GFP at the same time. ECs expressing PTX were detected only in the DA while mCherry expressing control ECs were also detected in the ISVs. Scale bar: 20 Âµm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 2.</label><caption><title>Apelin signaling functions cell-autonomously in ECs.</title><p>Confocal projection images of the trunk region of <italic>Tg(fli1a:EGFP)</italic> embryos at 54 hpf. At the blastula stage, cells from <italic>Tg(kdrl:HsHRAS-mCherry)</italic> embryos were transplanted into host embryos obtained from <italic>Tg(fli1a:EGFP) aplnra <sup>+/-</sup>; aplnrb <sup>+/-</sup></italic> incrosses. At 54 hpf, the mosaic embryos were imaged and the donor-derived ECs scored for their position. Notably, wild-type ECs transplanted into <italic>aplnr</italic> deficient embryos completely substituted for the lack of cells in the dorsal part of the vasculature at 54 hpf (<xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplement 1</xref>). Scale bar: 30 Âµm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig3-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Apelin signaling functions downstream of Notch signaling</title><p>It has been previously reported that Notch-deficient ECs outcompete wild-type ECs during ISV sprouting (<xref ref-type="bibr" rid="bib58">Siekmann and Lawson, 2007</xref>), an observation consistent with data in mouse (<xref ref-type="bibr" rid="bib32">Jakobsson et al., 2010</xref>; <xref ref-type="bibr" rid="bib53">Pitulescu et al., 2017</xref>). Since wild-type ECs similarly outcompete <italic>aplnr</italic> mutant ECs, we wanted to investigate potential links between Apelin and Notch signaling. Hence, we first blocked Notch signaling in <italic>Tg<sup>BAC</sup>(apln:EGFP)</italic> embryos by injecting a <italic>dll4</italic> MO. As previously reported (<xref ref-type="bibr" rid="bib44">Leslie et al., 2007</xref>; <xref ref-type="bibr" rid="bib58">Siekmann and Lawson, 2007</xref>), <italic>dll4</italic> morphants exhibited a hypersprouting ISV phenotype (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Notably, we also observed a clear increase in <italic>apln:</italic>EGFP expression in the ectopic sprouts (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). To test whether Apelin signaling is required as a downstream effector of Notch signaling during angiogenesis, we injected the <italic>dll4</italic> MO into the offspring of <italic>apln</italic> and <italic>aplnrb</italic> heterozygous parents and compared the phenotype in homozygous mutant embryos versus their wild-type siblings. Strikingly, the hypersprouting phenotype of <italic>dll4</italic> morphants was not present when Apln or Aplnrb function was lost (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1</xref>). To examine whether other hypersprouting phenotypes require Apelin signaling, we analyzed <italic>aplnrb, plexinD1 (plxnd1)</italic> double mutant embryos (<xref ref-type="fig" rid="fig4">Figure 4C,E</xref>). <italic>aplnrb</italic> mutant embryos exhibit reduced sprouting and <italic>plxnd1</italic> mutant embryos exhibit ectopic sprouting in line with published data (<xref ref-type="bibr" rid="bib65">Torres-VÃ¡zquez et al., 2004</xref>; <xref ref-type="fig" rid="fig4">Figure 4C,E</xref>). Loss of <italic>aplnrb</italic> function in the background of the <italic>plxnd1</italic> mutant did not alter its hypersprouting phenotype (<xref ref-type="fig" rid="fig4">Figure 4C,E</xref>), suggesting that it is independent of Apelin function. Similar results were obtained when we analyzed ectopic venous sprouting in response to <italic>bmp2b</italic> overexpression (<xref ref-type="bibr" rid="bib71">Wiley et al., 2011</xref>; <xref ref-type="fig" rid="fig4">Figure 4D,F</xref>). Together these data indicate that Apelin signaling is specifically required for Notch-modulated angiogenesis. To investigate whether <italic>apln</italic> expression is itself regulated by Notch signaling, we performed cell culture assays. We treated HUVECs with the Notch inhibitor DAPT and analyzed <italic>APLN</italic> expression by RT-qPCR. Consistent with the observations in zebrafish (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), we observed an increase in <italic>APLN</italic> expression upon Notch inhibition (<xref ref-type="fig" rid="fig4">Figure 4G</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4âsource data 1</xref>). Next, we activated Notch signaling by stimulating HUVECs with the Notch ligand DLL4. Conversely to the Notch inhibition data, activating Notch signaling in HUVECs suppressed <italic>APLN</italic> expression (<xref ref-type="fig" rid="fig4">Figure 4H</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4âsource data 1</xref>). Together these data suggest that the increased sprouting in response to Notch inhibition is, in part, driven by the upregulation of <italic>apln</italic>.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Apelin signaling functions downstream of Notch signaling in endothelial cells.</title><p>(<bold>A - D</bold>) Confocal projection images of the blood vasculature in the trunk region of <italic>Tg(flt1:tdTomato)</italic> (<bold>A</bold>) and <italic>Tg(fli1a:EGFP)</italic> (BâD) animals at 54 (BâD) and 72 (<bold>A</bold>) hpf. (<bold>A</bold>) Injection of a <italic>dll4</italic> morpholino leads to an increase in <italic>Tg<sup>BAC</sup>(apln:</italic>EGFP) expression. (<bold>B</bold>) Loss of Apelin function can block excessive endothelial sprouting in <italic>dll4</italic> morphants. (<bold>C, E</bold>) Angiogenic response in <italic>aplnrb <sup>-/-</sup>, plxnd1 <sup>-/-</sup></italic>, and <italic>aplnrb</italic> <sup>-/-</sup><italic>; plxnd1</italic> <sup>-/-</sup> embryos (arrowheads) (nÂ =Â 95). (<bold>D, F</bold>) Angiogenic response to <italic>bmp2b</italic> overexpression in <italic>aplnr</italic> <sup>+/-</sup> and <italic>aplnr</italic> <sup>-/-</sup> embryos (arrowheads). (<bold>E</bold>) Genotype of embryos for <italic>aplnrb</italic> after sorting them according to phenotype. (<bold>G</bold>) RT-qPCR analysis of <italic>APELIN</italic> mRNA levels in HUVECs treated with DAPT for 24 hr. Blocking Notch signaling with DAPT induces <italic>APELIN</italic> expression. (<bold>H</bold>) RT-qPCR analysis of <italic>APELIN</italic> mRNA levels in HUVECs cultured on DLL4 to activate Notch signaling. Activating Notch signaling represses <italic>APELIN</italic> expression. Arrowheads point to ectopic sprouts. n.s. not significant (two-tailed t-test). Ct values can be found in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4âsource data 1</xref>. Scale bars: A, C, 20 Âµm; B, 15 Âµm; D, 30 Âµm.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4âsource data 1.</label><caption><title>Ct values of RT-qPCR.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-55589-fig4-data1-v2.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 1.</label><caption><title>Apelin signaling functions downstream of Notch signaling in ECs.</title><p>Confocal projection images of the trunk region of <italic>Tg(fli1a:EGFP)</italic> embryos at 54 hpf. Loss of <italic>aplnrb</italic> function can rescue excessive endothelial sprouting in <italic>dll4</italic> morphants. Arrowheads point to ectopic sprouts and asterisks indicate missing DLAV fragments. Scale bar: 30 Âµm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig4-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Apelin signaling positively regulates EC metabolism</title><p>Because EC sprouting requires an increase in metabolic activity (<xref ref-type="bibr" rid="bib16">Dobrina and Rossi, 1983</xref>; <xref ref-type="bibr" rid="bib41">KrÃ¼tzfeldt et al., 1990</xref>; <xref ref-type="bibr" rid="bib47">Mertens et al., 1990</xref>; <xref ref-type="bibr" rid="bib13">De Bock et al., 2013a</xref>; <xref ref-type="bibr" rid="bib67">Vandekeere et al., 2015</xref>) and Apelin signaling has been shown to control cell metabolism in other contexts (<xref ref-type="bibr" rid="bib17">Dray et al., 2008</xref>; <xref ref-type="bibr" rid="bib55">Sawane et al., 2013</xref>), we asked whether Apelin signaling promotes EC metabolism. Previous studies have demonstrated that ECs rely on glycolysis for sprouting (<xref ref-type="bibr" rid="bib13">De Bock et al., 2013a</xref>; <xref ref-type="bibr" rid="bib67">Vandekeere et al., 2015</xref>). Therefore, we measured the extracellular acidification rate (ECAR) as a surrogate parameter of glycolysis in Apelin signaling-deficient HUVECs (<xref ref-type="fig" rid="fig5">Figure 5A,B</xref>). Notably, we observed a marked reduction in glycolysis after knockdown of Apelin signaling (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), whereas mitochondrial oxygen consumption appeared unchanged (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). To gain insight into the underlying mechanisms, we analyzed key regulators of metabolism and found a reduction in c-MYC protein levels after depletion of Apelin signaling (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Furthermore, expression of <italic>PFKFB3</italic>, which encodes an enzyme that sustains high glycolytic rates, was also reduced in Apelin signaling-deficient HUVECs (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). In order to analyze whether a reduction in EC metabolic activity causes the vascular phenotype observed in <italic>aplnrb</italic> mutants, we performed mosaic rescue experiments and overexpressed <italic>pfkfb3</italic> in ECs. In agreement with our in vitro data, we found that overexpression of <italic>pfkfb3</italic> in endothelial tip cells leads to a partial rescue of the vascular phenotype in <italic>aplnrb</italic> mutants (<xref ref-type="fig" rid="fig5">Figure 5E</xref> arrowheads, 5F, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4âsource data 1</xref>). Thus, Apelin signaling controls the expression of regulators of glucose metabolism as well as glycolytic activity in developing endothelial cells.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Apelin signaling positively regulates EC metabolism.</title><p>(<bold>A - B</bold>) Extracellular acidification aate (ECAR) (<bold>A</bold>) and oxygen consumption rates (OCR) (<bold>B</bold>) in siScr and <italic>APLN+APLNR</italic> siRNA-treated HUVECs under basal conditions and in response to oligomycin, fluoro-carbonyl cyanide phenylhydrazone (FCCP) and antimycin A (AA)/rotenone. (<bold>A</bold>) Reduced basal and maximal glycolytic activity in <italic>APLN+APLNR</italic> siRNA-treated compared to siScr-treated HUVECs. (<bold>B</bold>) No significant difference in oxygen consumption in <italic>APLN+APLNR</italic> siRNA-treated compared to siScr-treated HUVECs. (<bold>C</bold>) Reduced c-MYC levels in <italic>APLN+APLNR</italic> siRNA-treated compared to siScr-treated HUVECs. (<bold>D</bold>) RT-qPCR analysis of <italic>PFKFB3</italic> mRNA levels in <italic>APLN+APLNR</italic> siRNA-treated compared to siScr-treated HUVECs. (<bold>E</bold>) Confocal projection images of the blood vasculature in the trunk region of a 54 hpf <italic>Tg(kdrl:HsHRAS-mCherry)</italic> animal injected with an <italic>EGFP:fli1a:pfkfb3</italic> plasmid. Arrowheads point to formed DLAV fragments while asterisks indicate missing DLAV fragments. (<bold>F</bold>) Quantification of the rescue of the DLAV fragment by mosaic <italic>pfkfb3</italic> overexpression in <italic>aplnrb <sup>-/-</sup></italic> embryos. n.s. not significant (two-tailed t-test). Scale bar: E, 50 Âµm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 1.</label><caption><title>Schematic model.</title><p>Schematic model of the developing blood vessels in the zebrafish trunk depicting the expression of Apelin and Aplnr and the relationship between Notch signaling and <italic>Apln</italic> expression during ISV sprouting.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55589-fig5-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>During the formation of the first embryonic blood vessels, angioblasts migrate to the midline where they coalesce to form the future DA and cardinal vein. We have previously reported that vasculogenesis relies on the function of the ligand Apela (<xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref>). Here, we show that angiogenesis depends mostly on the function of the ligand Apln. However, Apela can partially compensate for the loss of Apln. This stage-specific ligand usage is in agreement with previous studies showing that <italic>apela</italic> expression is reduced by the end of vasculogenesis when <italic>apln</italic> starts to be expressed (<xref ref-type="bibr" rid="bib8">Chng et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Pauli et al., 2014</xref>).</p><p>During angiogenesis in embryos lacking Apelin signaling, we observed a severe sprouting defect with a reduction in EC numbers and filopodia. As ECs proliferate, extend filopodia, and migrate during ISV formation, it is challenging to assign the cause of the sprouting defect to the EC proliferation or filopodia formation defects. However, <xref ref-type="bibr" rid="bib51">Phng et al., 2013</xref> reported that the inhibition of filopodia formation by Latrunculin B treatment reduces ISV sprout length, suggesting that the ISV sprouting defects in <italic>apln</italic> mutants is caused by the filopodia defects. However, one cannot exclude the possibility that defects in EC numbers are also contributing to the ISV sprouting defects.</p><p>While we observed a severe angiogenesis phenotype when Apelin signaling was impaired, global overexpression of <italic>apln</italic> did not lead to ectopic sprouting. However, these experiments were done in the presence of endogenous Apelin, and thus, it is possible that the endogenous Apelin gradient prevents ECs from ectopic sprouting. In addition, Apelin might need to be expressed from a discrete source, rather than globally, to elicit a sprouting response.</p><p>During sprouting angiogenesis, ECs within a sprout are highly heterogenous in their shape, gene expression and function, which led to the model of tip and stalk cells (<xref ref-type="bibr" rid="bib19">Gerhardt et al., 2003</xref>). While differences in expression between tip and stalk cells have been reported for several genes (<xref ref-type="bibr" rid="bib61">Tammela et al., 2008</xref>), (<xref ref-type="bibr" rid="bib28">HellstrÃ¶m et al., 2007</xref>; <xref ref-type="bibr" rid="bib58">Siekmann and Lawson, 2007</xref>; <xref ref-type="bibr" rid="bib44">Leslie et al., 2007</xref>; <xref ref-type="bibr" rid="bib59">Suchting et al., 2007</xref>; <xref ref-type="bibr" rid="bib15">del Toro et al., 2010</xref>; <xref ref-type="bibr" rid="bib3">Bussmann et al., 2011</xref>; <xref ref-type="bibr" rid="bib29">Herbert et al., 2012</xref>), little is known about the molecular differences between sprouting and resting ECs (<xref ref-type="bibr" rid="bib56">Schlereth et al., 2018</xref>). By analyzing novel reporter lines for <italic>apln</italic> and <italic>aplnrb</italic> expression, we observed high <italic>apln</italic> expression in tip cells while we could not observe any difference in <italic>aplnrb</italic> expression between tip and stalk cells (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1</xref>). Interestingly, <italic>aplnrb</italic> is highly expressed in sprouting ECs in ISVs while being absent from non-angiogenic ECs in the DA (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1</xref>). These observations are in line with a recent study showing that ECs during tumor angiogenesis can be labeled by a <italic>CreERT2</italic> transgene in the <italic>Aplnr</italic> locus while quiescent blood vessels in the surrounding tissue are not labeled (<xref ref-type="bibr" rid="bib74">Zhao et al., 2018</xref>).</p><p>At the molecular level, vascular sprouting and cell positioning within the sprout is tightly regulated by VEGF and Notch signalingÂ (<xref ref-type="bibr" rid="bib28">HellstrÃ¶m et al., 2007</xref>; <xref ref-type="bibr" rid="bib45">Lobov et al., 2007</xref>; <xref ref-type="bibr" rid="bib58">Siekmann and Lawson, 2007</xref>; <xref ref-type="bibr" rid="bib59">Suchting et al., 2007</xref>; <xref ref-type="bibr" rid="bib32">Jakobsson et al., 2010</xref>). In addition to these signaling pathways, we propose Apelin signaling as a molecular switch to drive ECs into a pro-angiogenic state. In line with the expression of <italic>aplnrb</italic> in sprouting but not quiescent ECs, we show that <italic>aplnrb</italic> function regulates the ability of ECs to sprout or stay quiescent. Similarly, Notch signaling regulates the behavior of ECs (<xref ref-type="bibr" rid="bib58">Siekmann and Lawson, 2007</xref>): <italic>rbpj</italic> deficient ECs contribute to the ISVs while wild-type ECs stay within the DA (<xref ref-type="bibr" rid="bib58">Siekmann and Lawson, 2007</xref>). Of note, we found that Notch signaling regulates the expression of <italic>apln</italic> in vitro as well as in vivo and that Apelin signaling is a key downstream effector of Notch signaling during angiogenesis (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1</xref>). However, it is very unlikely that <italic>apln</italic> is a direct Notch target gene since activation of Notch signaling leads to a downregulation of <italic>APLN</italic> expression. Thus far, two downstream effectors of Notch signaling have been reported to control angiogenesis namely PTEN (<xref ref-type="bibr" rid="bib57">Serra et al., 2015</xref>) and CXCR4, another GPCR (<xref ref-type="bibr" rid="bib23">Hasan et al., 2017</xref>; <xref ref-type="bibr" rid="bib53">Pitulescu et al., 2017</xref>). While PTEN has been shown to be required for Notch induced arrest in EC proliferation (<xref ref-type="bibr" rid="bib57">Serra et al., 2015</xref>), CXCR4 mediates Notch-controlled EC migration (<xref ref-type="bibr" rid="bib23">Hasan et al., 2017</xref>; <xref ref-type="bibr" rid="bib53">Pitulescu et al., 2017</xref>). PTEN and Apelin both regulate AKT phosphorylation (<xref ref-type="bibr" rid="bib12">Davies et al., 1998</xref>; <xref ref-type="bibr" rid="bib46">Masri et al., 2004</xref>). Thus, one might speculate that AKT function is a common effector of PTEN and Apelin signaling in EC proliferation. Furthermore, we found that Apelin was required for EC migration in the absence of Notch signaling. Similarly, CXCR4 is required for EC migration in the absence of Notch signaling (<xref ref-type="bibr" rid="bib23">Hasan et al., 2017</xref>; <xref ref-type="bibr" rid="bib53">Pitulescu et al., 2017</xref>). CXCR4 and APLNR both signal through the G-protein GÎ±i (<xref ref-type="bibr" rid="bib48">Moepps et al., 1997</xref>; <xref ref-type="bibr" rid="bib21">Habata et al., 1999</xref>), and they might therefore have similar effects. Gpr124, another GPCR, has been reported to be required in tip cells during zebrafish angiogenesis (<xref ref-type="bibr" rid="bib68">Vanhollebeke et al., 2015</xref>), similar to Aplnr. However, Gpr124 is required in tip cells only in the brain (<xref ref-type="bibr" rid="bib68">Vanhollebeke et al., 2015</xref>), while Aplnr is required in tip cells in the ISVs, where it is most highly expressed.</p><p>Sprouting angiogenesis is controlled by genetically encoded signal transducers as well as by the metabolic state. However, how environmental signals modulate the metabolic activity of ECs is incompletely understood. Here, we show that Apelin signaling regulates the expression of <italic>PFKFB3</italic> and c-MYC, two powerful drivers of EC metabolism (<xref ref-type="bibr" rid="bib72">Wilhelm et al., 2016</xref>; <xref ref-type="bibr" rid="bib14">De Bock et al., 2013b</xref>). Recently it has been shown that Apelin signaling promotes FOXO1 phosphorylation (<xref ref-type="bibr" rid="bib31">Hwangbo et al., 2017</xref>), which negatively regulates its activity. Consistent with these findings, FOXO1 has been shown to suppress c-MYC expression (<xref ref-type="bibr" rid="bib72">Wilhelm et al., 2016</xref>). Together these data raise the possibility that Apelin signals through FOXO1 to regulate c-MYC levels. Of note, genetic deletion of <italic>Pfkfb3</italic> in mouse ECs leads to a reduction in their number as well as defects in filopodia formation and extension (<xref ref-type="bibr" rid="bib14">De Bock et al., 2013b</xref>), phenocopying <italic>aplnr</italic> mutant embryos.</p><p>Taken together, our findings provide novel insights into a druggable pathway regulating angiogenesis and suggest that manipulating the angiogenic state of ECs by controlling Apln signaling might have therapeutic potential to control vascular growth in pathological settings.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(fli1a:EGFP)<sup>y1</sup></italic></td><td><xref ref-type="bibr" rid="bib43">Lawson and Weinstein, 2002</xref></td><td>ZFIN: <italic>y1</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(fli1a:nEGFP)<sup>y7</sup></italic></td><td><xref ref-type="bibr" rid="bib54">Roman et al., 2002</xref>,</td><td>ZFIN: <italic>y7</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(kdrl:HsHRAS-mCherry)<sup>s896</sup></italic></td><td><xref ref-type="bibr" rid="bib7">Chi et al., 2008</xref></td><td>ZFIN: <italic>s896</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>aplnra<sup>mu296</sup></italic></td><td><xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref></td><td>ZFIN: <italic>mu296</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>aplnrb<sup>mu281</sup></italic></td><td>codes for another allele of <italic>aplnrb</italic> from <xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref></td><td>ZFIN: <italic>mu281</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>apln<sup>mu26</sup></italic><sup>7</sup></td><td><xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref></td><td>ZFIN: <italic>mu267</italic></td><td/></tr><tr><td>genetic reagent <break/>(<italic>D. rerio</italic>)</td><td><italic>Tg(hsp70:bmp2b)<sup>fr13</sup></italic></td><td><xref ref-type="bibr" rid="bib9">Chocron et al., 2007</xref></td><td>ZFIN: <italic>fr13</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>apela<sup>br13</sup></italic></td><td><xref ref-type="bibr" rid="bib8">Chng et al., 2013</xref>,</td><td>ZFIN: <italic>br13</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(fli:lifeact-GFP)<sup>mu240</sup></italic></td><td><xref ref-type="bibr" rid="bib22">Hamm et al., 2016</xref></td><td>ZFIN: <italic>mu240</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(fli1a:Hsa.B4GALT1-mCherry)<sup>bns9</sup></italic></td><td><xref ref-type="bibr" rid="bib42">Kwon et al., 2016</xref></td><td>ZFIN: <italic>bns9</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(hsp70:apln)<sup>mu269</sup></italic></td><td>This manuscript</td><td>ZFIN: <italic>mu269</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(kdrl:HsHRAS-EGFP)<sup>mu280</sup></italic></td><td>This manuscript</td><td>ZFIN: <italic>mu280</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(apln:EGFP)<sup>bns157</sup></italic></td><td>This manuscript</td><td>ZFIN: <italic>bns157</italic></td><td/></tr><tr><td>genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(aplnrb:aplnrb-TagRFP-</italic> <break/><italic>sfGFP)<sup>bns309</sup></italic></td><td>This manuscript</td><td>ZFIN: <italic>bns309</italic></td><td/></tr><tr><td>antibody</td><td>anti-FOXO1 (rabbit monoclonal)</td><td>Cell Signaling Technology</td><td>Cat#2880</td><td>(1:1000)</td></tr><tr><td>antibody</td><td>anti-pThr24FOXO1/pThr32FOXO3a (rabbit monoclonal)</td><td>Cell Signaling Technology</td><td>Cat#9464</td><td>(1:1000)</td></tr><tr><td>antibody</td><td>anti-c-MYC (rabbit polyclonal)</td><td>Cell Signaling Technology</td><td>Cat#9402</td><td>(1:1000)</td></tr><tr><td>antibody</td><td>anti-Tubulin (rabbit polyclonal)</td><td>Cell Signaling Technology</td><td>Cat#2148</td><td>(1:1000)</td></tr><tr><td>other</td><td>Taqman probe <italic>APLN</italic></td><td>Thermo Fisher Scientific</td><td>Hs00175572_m1</td><td/></tr><tr><td valign="top">other</td><td>Taqman probe <italic>APLNR</italic></td><td>Thermo Fisher Scientific</td><td>Hs00270873_s1</td><td/></tr><tr><td valign="top">other</td><td>Taqman probe <italic>PFKFB3</italic></td><td>Thermo Fisher Scientific</td><td>Hs00270873_s1</td><td/></tr><tr><td valign="top">other</td><td>Taqman probe <italic>ACTB</italic></td><td>Thermo Fisher Scientific</td><td>Hs01060665_g1</td><td/></tr><tr><td>commercial assay or kit</td><td>In-Fusion HD Cloning Plus</td><td>Takara Bio</td><td>Cat# 638910</td><td/></tr><tr><td>transfected construct (human)</td><td><italic>APLN</italic></td><td>Dharmacon</td><td>Cat# L-017023-01-0005</td><td>50 nM</td></tr><tr><td valign="top">transfected construct (human)</td><td><italic>APLNR</italic></td><td>Dharmacon</td><td>Cat# L-005430-00-0005</td><td>50 nM</td></tr><tr><td valign="top">transfected construct (human)</td><td>ON-TARGETplus Non-targeting Pool</td><td>Dharmacon</td><td>Cat# D-001810-10-05</td><td>50 nM</td></tr><tr><td>commercial assay or kit</td><td>mMessage mMachine SP6 Transcription Kit</td><td>Thermo Fisher Scientific</td><td>Cat# AM1340</td><td/></tr><tr><td>commercial assay or kit</td><td>DIG RNA labelling kit</td><td>Roche</td><td>Cat# 11277073910</td><td/></tr><tr><td>commercial assay or kit</td><td>SuperScript III First-Strand Synthesis System</td><td>Thermo Fisher Scientific</td><td>Cat#18080051</td><td/></tr><tr><td>commercial assay or kit</td><td>RNA Clean and Concentrator Kit</td><td>Zymo Research</td><td>Cat# R1013</td><td/></tr><tr><td>software, algorithm</td><td>ZEN Blue 2012</td><td>Zeiss, Germany</td><td/><td/></tr><tr><td valign="top">software, algorithm</td><td>ZEN Black 2012</td><td>Zeiss, Germany</td><td/><td/></tr><tr><td valign="top">software, algorithm</td><td>Imaris - Version 8.4.0</td><td>Bitplane, UK</td><td/><td/></tr><tr><td valign="top">software, algorithm</td><td>GraphPad Prism 6</td><td>GraphPad Software, USA</td><td/><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Zebrafish husbandry and strains</title><p>All zebrafish housing and husbandry were performed under standard conditions in accordance with institutional (Max Planck Society) and national ethical and animal welfare guidelines approved by the ethics committee for animal experiments at the RegierungsprÃ¤sidium Darmstadt, Germany, as well as the FELASA guidelines (<xref ref-type="bibr" rid="bib2">AlestrÃ¶m et al., 2020</xref>). Embryos were staged by hours post fertilization (hpf) at 28.5Â°C (<xref ref-type="bibr" rid="bib38">Kimmel et al., 1995</xref>). The following lines were used: <italic>Tg(fli1a:EGFP)<sup>y1</sup></italic> (<xref ref-type="bibr" rid="bib43">Lawson and Weinstein, 2002</xref>), <italic>Tg(fli1a:nEGFP)<sup>y7</sup></italic> (<xref ref-type="bibr" rid="bib54">Roman et al., 2002</xref>), <italic>Tg(kdrl:HsHRAS-mCherry)<sup>s896</sup></italic> (<xref ref-type="bibr" rid="bib7">Chi et al., 2008</xref>), <italic>aplnra<sup>mu296</sup></italic> (<xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref>), the <italic>aplnrb<sup>mu281</sup></italic> allele was generated using the same CRISPR as in <xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref> and contains a 4 bp insertion 137 bp downstream of the ATG leading to a premature stop codon 196 bp downstream of the ATG, <italic>apln<sup>mu26</sup></italic><sup>7</sup> (<xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref>), <italic>Tg(hsp70:bmp2b)<sup>fr13</sup></italic> (<xref ref-type="bibr" rid="bib9">Chocron et al., 2007</xref>), <italic>apela<sup>br13</sup></italic> (<xref ref-type="bibr" rid="bib8">Chng et al., 2013</xref>), <italic>Tg(fli1a:LIFEACT-GFP)<sup>mu240</sup></italic> (<xref ref-type="bibr" rid="bib22">Hamm et al., 2016</xref>), <italic>Tg(fli1a:Hsa.B4GALT1-mCherry)<sup>bns9</sup></italic> (<xref ref-type="bibr" rid="bib42">Kwon et al., 2016</xref>)<italic>, Tg(hsp70:apln)<sup>mu269</sup></italic> (this study), <italic>Tg(kdrl:HsHRAS-EGFP)<sup>mu280</sup></italic> (this study), <italic>Tg(apln:EGFP)<sup>bns157</sup></italic> (this study) and <italic>Tg(aplnrb:aplnrb-TagRFP-sfGFP)<sup>bns309</sup></italic> (this study).</p></sec><sec id="s4-2"><title>Generation of the <italic>Tg<sup>BAC</sup>(apln:EGFP)<sup>bns157</sup></italic>, <italic>Tg<sup>BAC</sup>(aplnrb:aplnrb-TagRFP-sfGFP)<sup>bns309</sup></italic>, <italic>Tg(kdrl:HsHRAS-EGFP)<sup>mu280,Â </sup></italic>and <italic>Tg(hsp70l:apln)<sup>mu269</sup>lines</italic></title><p>To generate the <italic>apln</italic> and <italic>aplnrb</italic> bacterial artificial chromosome (BAC) constructs, we used the BAC clones RP71-2G21 containing the <italic>apln</italic> locus and CH211-102K containing the <italic>aplnrb</italic> locus. All recombineering steps were performed as described in <xref ref-type="bibr" rid="bib4">Bussmann and Schulte-Merker, 2011</xref> with the modifications as described in <xref ref-type="bibr" rid="bib27">Helker et al., 2019</xref>. The following homology arms were used to generate the targeting PCR products of the EGFP_Kan, and TagRFP-sfGFP_Kan cassettes:<italic>apln</italic>-HA1: 5â-<named-content content-type="sequence">ccactacagtatatcagctagcgactggcagggaaacggaggggagagcaaccatggtgagcaagggcgaggag</named-content>-3â and <italic>apln</italic>-HA2: 5â-<named-content content-type="sequence">cacagcagagaaaccaccagcacaatcaccagcgtcaagatcttcacattttccagaagtagtgaggag</named-content>-3â;<italic>aplnrb</italic>-HA1:5â-<named-content content-type="sequence">gctccctttcttcacagaagaccgaggcccagtcgctggctacgaaggtgcttggacctggactcggatc</named-content>-â3 and <italic>aplnrb</italic>-HA2: 5â-<named-content content-type="sequence">taattgctgacttgttaccccaattctgcgtcacccttccgttctcctcctgaccatgattacgccaagc</named-content>-â3.</p><p>To generate the <italic>Tg(kdrl:HsHRAS-EGFP)</italic> and <italic>Tg(hsp70:apln) lines,</italic> the gateway recombination system (Invitrogen) using entry vectors and the pTolDest destination vector (<xref ref-type="bibr" rid="bib69">Villefranc et al., 2007</xref>) was used. The <italic>apln</italic> coding sequence was amplified from cDNA. 100 pg DNA of the plasmids and 50 pg of tol2 mRNA were injected into one-cell stage zebrafish embryos for stable germline transmission.</p></sec><sec id="s4-3"><title>Morpholino injections</title><p>Morpholinos were obtained from Gene Tools, resuspended in distilled H<sub>2</sub>O and around 2 nl was injected into 1 cell stage embryos. The following morpholinos were used: <italic>aplnrb</italic> MO (<xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref>) at 0.5 ng/embryo, <italic>dll4</italic> MO (<xref ref-type="bibr" rid="bib30">Hogan et al., 2009</xref>) at 3 ng/embryo. An equal amount of the standard control MO: 5â-<named-content content-type="sequence">CCTCTTACCTCAGTTACAATTTATA</named-content>-3â was used for each experiment.</p></sec><sec id="s4-4"><title>Transplantation experiments</title><p>At the sphere stage, cells were removed from <italic>Tg(kdrl:HsHRAS-mCherry)</italic> donor embryos and transferred to <italic>Tg(fli1a:EGFP) aplnr</italic> mutant hosts using a glass capillary. Transplanted ECs were identified by transgenic mCherry expression.</p></sec><sec id="s4-5"><title>Whole-mount in situ hybridization</title><p>Single in situ hybridizations were performed as described (<xref ref-type="bibr" rid="bib64">Thisse and Thisse, 2008</xref>; <xref ref-type="bibr" rid="bib25">Helker et al., 2013</xref>). The following probes were synthesized: <italic>apln</italic> (<xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref>), <italic>apela</italic> (<xref ref-type="bibr" rid="bib8">Chng et al., 2013</xref>), <italic>aplnra</italic> (<xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref>), and <italic>aplnrb</italic> (<xref ref-type="bibr" rid="bib26">Helker et al., 2015</xref>).</p></sec><sec id="s4-6"><title>Confocal microscopy</title><p>Zebrafish larvae were mounted in 1% low melt agarose. Egg water and agarose were supplemented with 19.2 mg/l Tricaine. All fluorescent images were acquired using an upright Zeiss LSM 780, 800 or 880 or a Leica SP5 or SP8 confocal microscope. Maximum projection images were analyzed and generated using Imaris (Bitplane).</p></sec><sec id="s4-7"><title>Quantification of mutant phenotypes</title><p>For every embryo, somites 5 to 15 were analyzed (normal: 10 fully developed ISVs and connected DLAV; mild: 10 ISVs fully developed but no DLAV; strong: 1 to 6 ISVs shortened; severe: 1 to 10 ISVs shortened).</p></sec><sec id="s4-8"><title>Quantification of filopodia</title><p>Only filopodia with more than 10 Âµm in length were used for quantification.</p><p>ISVs were categorized as filopodia rich ISVs (more than six filopodia) or filopodia poor ISVs (less than six filopodia). A total of 49 ISVs were quantified for the Ctr MO and 103 ISVs for the <italic>aplnrb</italic> MO.</p></sec><sec id="s4-9"><title><italic>pfkfb3</italic> rescue experiments</title><p><italic>pfkfb3</italic> was cloned downstream of a bidirectional <italic>fli1a</italic> promoter driving <italic>EGFP</italic> in one direction and <italic>pfkfb3</italic> in the other direction. <italic>aplnrb</italic> mutant embryos were injected with 20 pg <italic>EGFP:fli1a:pfkfb3</italic> DNA and 30 pg Tol2 mRNA to generate mosaic blood vessels. EGFP positive tip cells were analyzed to quantify the percentage of connected DLAV segments. Neighboring EGFP negative tip cells were used as controls.</p></sec><sec id="s4-10"><title>Cell culture</title><p>Pooled human umbilical vein endothelial cells (HUVECs) were purchased from Lonza (#CC-2519) and cultured in endothelial basal medium (EBM, Lonza) supplemented with hydrocortisone (1 Î¼g/ml), bovine brain extract (12 Î¼g/ml), gentamicin (50 Î¼g/ml), amphotericin B (50 ng/ml), epidermal growth factor (10 ng/ml), and 10% fetal bovine serum (FBS, Life Technologies). HUVECs were tested for mycoplasma and cultured until the fourth passage. Cells were maintained at 37Â°C in a humidified atmosphere with 5% CO<sub>2</sub>.</p></sec><sec id="s4-11"><title>RNA interference</title><p>To silence <italic>APLN</italic> and <italic>APLNR</italic> gene expression, HUVECs were transfected with 50 nM APLN and APLNR ON-TARGET SMARTpool siRNA (Dharmacon). As a control, a non-targeting siRNA pool was used (Dharmacon). HUVECs were grown to 70% confluency and transfected with Lipofectamine RNAiMAX (Life Technologies) according to manufacturer's instructions.</p></sec><sec id="s4-12"><title>Western blot analysis and antibodies</title><p>Western blot analyses were performed with precast gradient gels (Bio-Rad) using standard methods. Briefly, cells were lysed in RIPA buffer (Sigma; 150 mM NaCl, 1.0% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS, and 50 mM Tris, pH 8.0) supplemented with Complete Protease Inhibitor Cocktail (Roche) and 1 mM PMSF. Proteins were separated by SDS-PAGE (Tris-glycine gels with Tris/glycine/SDS buffer, Bio-Rad) and transferred onto nitrocellulose membranes using the Trans Turbo Blot system (Bio-Rad). Membranes were probed with specific primary antibodies and then with peroxidase-conjugated secondary antibodies. The following primary antibodies were used: FOXO1 (Cell Signaling Technology, #2880, 1:1000), pThr24FOXO1/pThr32FOXO3a (Cell Signaling Technology, #9464, 1:1000), c-MYC (Cell Signaling Technology, #9402, 1:1000), Tubulin (Cell Signaling Technology, #2148, 1:1000), Secondary antibodies are peroxidase-conjugated Goat IgGs (1:5000) purchased from Jackson Immuno Research Labs. The target proteins were visualized by chemiluminescence using an ECL detection kit (Clarity Western ECL Substrate, Bio-Rad) and a ChemiDoc MP Imaging System (Bio-Rad).</p></sec><sec id="s4-13"><title>RT-qPCR</title><p>Total RNA from HUVECs was extracted using a RNeasy Mini Kit (Qiagen). Reverse transcription polymerase chain reaction (RT-PCR) was performed using a SuperScript III First-Strand Synthesis System (Invitrogen) according to manufacturerâs instructions. RT-qPCR was carried out to quantify gene expression levels on a CFX connect Realtime System (Bio-Rad) with the following Taqman probes: <italic>APLN</italic> Hs00175572_m1, <italic>APLNR</italic> Hs00270873_s1, <italic>PFKFB3</italic> Hs00270873_s1. Each sample was normalized to the housekeeping probe <italic>ACTB</italic> Hs01060665_g1.</p></sec><sec id="s4-14"><title>Metabolic assay</title><p>The metabolism of cells was assessed by the measurement of extracellular acidification (ECAR) and oxygen consumption rates (OCR) using a Seahorse XFe96 analyser (Agilent). Four hours before the measurement, 40.000 HUVECs per well were seeded in a fibronectin-coated XFe96 microplate. The measurement was done following manufacturerâs protocol. To monitor glycolysis, the glycolysis stress test kit was used. The following substances were sequentially injected after a baseline measurement: Glucose (10 mM), Oligomycin (3 ÂµM) and 2-Deoxyglucose (2-DG; 100 mM). The oxygen consumption rate was assessed using the Mito stress test kit. After a baseline measurement, the following substances were sequentially injected: Oligomycin (3 ÂµM), the mitochondrial uncoupler carbonyl cyanide-4-(trifluoromethoxy)phenyl-hydrazone (FCCP; 1 ÂµM) as well as a mixture of antimycin A (1.5 ÂµM) and rotenone (3 ÂµM).</p></sec><sec id="s4-15"><title>Statistics</title><p>Standard error of the mean and P-values from a two-tailed t-test were calculated using Prism.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Radhan Ramadass and the Marburg Center of Advanced Light Microscopy, Marianne Ploch and all the fish facility staff for technical support; Teja Mullapudi, Giulia Boezio, Jialing Qi and Constanze Heinzen for suggestions and critical comments on the project. Research in the Herzog laboratory was supported by the North Rhine-Westphalia 'return fellowship' and the DFG (HE4585/3-1). Research in the Potente laboratory is supported by the Max Planck Society, the European Research Council (ERC) Consolidator Grant EMERGE (773047), the DFG (SFB 834), the Excellence Cluster Cardio-Pulmonary Institute (EXC 2026, Project ID: 390649896), the DZHK (German Center for Cardiovascular Research), and a grant by the Leducq Foundation. Research in the Stainier laboratory is supported in part by the Max Planck Society, the DFG (SFB 834/4), the EU (ERC AdG project: ZMOD 694455) and the Leducq Foundation, and in the Helker laboratory by the DFG (SFB 834/4) and GRK2213.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Senior editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Writing - review and editing, equal contribution with Toshiya Sugino</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing - review and editing, equal contribution with Kerstin Wilhelm</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Supervision, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Supervision, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Ethics Statement All zebrafish husbandry was performed under standard conditions, and all experiments were conducted in accordance with institutional (MPG) and national ethical and animal welfare guidelines (Proposal numbers: B2/1017, B2/1041, B2/1218, B2/1138). All procedures conform to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-55589-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alastalo</surname> <given-names>TP</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Perez</surname> <given-names>VJ</given-names></name><name><surname>Pham</surname> <given-names>D</given-names></name><name><surname>Sawada</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>JK</given-names></name><name><surname>Koskenvuo</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Freeman</surname> <given-names>BA</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name><name><surname>Rabinovitch</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Disruption of PPARÎ³/Î²-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival</article-title><source>Journal of Clinical Investigation</source><volume>121</volume><fpage>3735</fpage><lpage>3746</lpage><pub-id pub-id-type="doi">10.1172/JCI43382</pub-id><pub-id pub-id-type="pmid">21821917</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>AlestrÃ¶m</surname> <given-names>P</given-names></name><name><surname>DâAngelo</surname> <given-names>L</given-names></name><name><surname>Midtlyng</surname> <given-names>PJ</given-names></name><name><surname>Schorderet</surname> <given-names>DF</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name><name><surname>Sohm</surname> <given-names>F</given-names></name><name><surname>Warner</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Zebrafish: housing and husbandry recommendations</article-title><source>Laboratory Animals</source><volume>54</volume><fpage>213</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1177/0023677219869037</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bussmann</surname> <given-names>J</given-names></name><name><surname>Wolfe</surname> <given-names>SA</given-names></name><name><surname>Siekmann</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Arterial-venous network formation during brain vascularization involves hemodynamic regulation of chemokine signaling</article-title><source>Development</source><volume>138</volume><fpage>1717</fpage><lpage>1726</lpage><pub-id pub-id-type="doi">10.1242/dev.059881</pub-id><pub-id pub-id-type="pmid">21429983</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bussmann</surname> <given-names>J</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rapid BAC selection for tol2-mediated transgenesis in zebrafish</article-title><source>Development</source><volume>138</volume><fpage>4327</fpage><lpage>4332</lpage><pub-id pub-id-type="doi">10.1242/dev.068080</pub-id><pub-id pub-id-type="pmid">21865323</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname> <given-names>SM</given-names></name><name><surname>Razavi</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Agrawal</surname> <given-names>R</given-names></name><name><surname>Kundu</surname> <given-names>RK</given-names></name><name><surname>de Jesus Perez</surname> <given-names>V</given-names></name><name><surname>Zamanian</surname> <given-names>RT</given-names></name><name><surname>Quertermous</surname> <given-names>T</given-names></name><name><surname>Chun</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>31</volume><fpage>814</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.110.219980</pub-id><pub-id pub-id-type="pmid">21233449</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>T</given-names></name><name><surname>Wu</surname> <given-names>B</given-names></name><name><surname>Lin</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Association of apelin and apelin receptor with the risk of coronary artery disease: a meta-analysis of observational studies</article-title><source>Oncotarget</source><volume>8</volume><fpage>57345</fpage><lpage>57355</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.17360</pub-id><pub-id pub-id-type="pmid">28915675</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname> <given-names>NC</given-names></name><name><surname>Shaw</surname> <given-names>RM</given-names></name><name><surname>De Val</surname> <given-names>S</given-names></name><name><surname>Kang</surname> <given-names>G</given-names></name><name><surname>Jan</surname> <given-names>LY</given-names></name><name><surname>Black</surname> <given-names>BL</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Foxn4 directly regulates tbx2b expression and atrioventricular canal formation</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>734</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1101/gad.1629408</pub-id><pub-id pub-id-type="pmid">18347092</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chng</surname> <given-names>SC</given-names></name><name><surname>Ho</surname> <given-names>L</given-names></name><name><surname>Tian</surname> <given-names>J</given-names></name><name><surname>Reversade</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>ELABELA: a hormone essential for heart development signals via the apelin receptor</article-title><source>Developmental Cell</source><volume>27</volume><fpage>672</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2013.11.002</pub-id><pub-id pub-id-type="pmid">24316148</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chocron</surname> <given-names>S</given-names></name><name><surname>Verhoeven</surname> <given-names>MC</given-names></name><name><surname>Rentzsch</surname> <given-names>F</given-names></name><name><surname>Hammerschmidt</surname> <given-names>M</given-names></name><name><surname>Bakkers</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Zebrafish Bmp4 regulates left-right asymmetry at two distinct developmental time points</article-title><source>Developmental Biology</source><volume>305</volume><fpage>577</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2007.03.001</pub-id><pub-id pub-id-type="pmid">17395172</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname> <given-names>HJ</given-names></name><name><surname>Ali</surname> <given-names>ZA</given-names></name><name><surname>Kojima</surname> <given-names>Y</given-names></name><name><surname>Kundu</surname> <given-names>RK</given-names></name><name><surname>Sheikh</surname> <given-names>AY</given-names></name><name><surname>Agrawal</surname> <given-names>R</given-names></name><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Leeper</surname> <given-names>NJ</given-names></name><name><surname>Pearl</surname> <given-names>NE</given-names></name><name><surname>Patterson</surname> <given-names>AJ</given-names></name><name><surname>Anderson</surname> <given-names>JP</given-names></name><name><surname>Tsao</surname> <given-names>PS</given-names></name><name><surname>Lenardo</surname> <given-names>MJ</given-names></name><name><surname>Ashley</surname> <given-names>EA</given-names></name><name><surname>Quertermous</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Apelin signaling antagonizes ang II effects in mouse models of atherosclerosis</article-title><source>Journal of Clinical Investigation</source><volume>118</volume><fpage>3343</fpage><lpage>3354</lpage><pub-id pub-id-type="doi">10.1172/JCI34871</pub-id><pub-id pub-id-type="pmid">18769630</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>CM</given-names></name><name><surname>D'Agostino</surname> <given-names>SL</given-names></name><name><surname>Miller</surname> <given-names>MK</given-names></name><name><surname>Heimark</surname> <given-names>RL</given-names></name><name><surname>Krieg</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo</article-title><source>Developmental Biology</source><volume>296</volume><fpage>177</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.04.452</pub-id><pub-id pub-id-type="pmid">16750822</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>MA</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Sano</surname> <given-names>T</given-names></name><name><surname>Fang</surname> <given-names>X</given-names></name><name><surname>Tang</surname> <given-names>P</given-names></name><name><surname>LaPushin</surname> <given-names>R</given-names></name><name><surname>Koul</surname> <given-names>D</given-names></name><name><surname>Bookstein</surname> <given-names>R</given-names></name><name><surname>Stokoe</surname> <given-names>D</given-names></name><name><surname>Yung</surname> <given-names>WK</given-names></name><name><surname>Mills</surname> <given-names>GB</given-names></name><name><surname>Steck</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>'Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis'</article-title><source>Cancer Research</source><volume>58</volume><fpage>5285</fpage><lpage>5290</lpage><pub-id pub-id-type="pmid">9850049</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Bock</surname> <given-names>K</given-names></name><name><surname>Georgiadou</surname> <given-names>M</given-names></name><name><surname>Carmeliet</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Role of endothelial cell metabolism in vessel sprouting</article-title><source>Cell Metabolism</source><volume>18</volume><fpage>634</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2013.08.001</pub-id><pub-id pub-id-type="pmid">23973331</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Bock</surname> <given-names>K</given-names></name><name><surname>Georgiadou</surname> <given-names>M</given-names></name><name><surname>Schoors</surname> <given-names>S</given-names></name><name><surname>Kuchnio</surname> <given-names>A</given-names></name><name><surname>Wong</surname> <given-names>BW</given-names></name><name><surname>Cantelmo</surname> <given-names>AR</given-names></name><name><surname>Quaegebeur</surname> <given-names>A</given-names></name><name><surname>GhesquiÃ¨re</surname> <given-names>B</given-names></name><name><surname>Cauwenberghs</surname> <given-names>S</given-names></name><name><surname>Eelen</surname> <given-names>G</given-names></name><name><surname>Phng</surname> <given-names>LK</given-names></name><name><surname>Betz</surname> <given-names>I</given-names></name><name><surname>Tembuyser</surname> <given-names>B</given-names></name><name><surname>Brepoels</surname> <given-names>K</given-names></name><name><surname>Welti</surname> <given-names>J</given-names></name><name><surname>Geudens</surname> <given-names>I</given-names></name><name><surname>Segura</surname> <given-names>I</given-names></name><name><surname>Cruys</surname> <given-names>B</given-names></name><name><surname>Bifari</surname> <given-names>F</given-names></name><name><surname>Decimo</surname> <given-names>I</given-names></name><name><surname>Blanco</surname> <given-names>R</given-names></name><name><surname>Wyns</surname> <given-names>S</given-names></name><name><surname>Vangindertael</surname> <given-names>J</given-names></name><name><surname>Rocha</surname> <given-names>S</given-names></name><name><surname>Collins</surname> <given-names>RT</given-names></name><name><surname>Munck</surname> <given-names>S</given-names></name><name><surname>Daelemans</surname> <given-names>D</given-names></name><name><surname>Imamura</surname> <given-names>H</given-names></name><name><surname>Devlieger</surname> <given-names>R</given-names></name><name><surname>Rider</surname> <given-names>M</given-names></name><name><surname>Van Veldhoven</surname> <given-names>PP</given-names></name><name><surname>Schuit</surname> <given-names>F</given-names></name><name><surname>Bartrons</surname> <given-names>R</given-names></name><name><surname>Hofkens</surname> <given-names>J</given-names></name><name><surname>Fraisl</surname> <given-names>P</given-names></name><name><surname>Telang</surname> <given-names>S</given-names></name><name><surname>Deberardinis</surname> <given-names>RJ</given-names></name><name><surname>Schoonjans</surname> <given-names>L</given-names></name><name><surname>Vinckier</surname> <given-names>S</given-names></name><name><surname>Chesney</surname> <given-names>J</given-names></name><name><surname>Gerhardt</surname> <given-names>H</given-names></name><name><surname>Dewerchin</surname> <given-names>M</given-names></name><name><surname>Carmeliet</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>Role of PFKFB3-driven glycolysis in vessel sprouting</article-title><source>Cell</source><volume>154</volume><fpage>651</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.06.037</pub-id><pub-id pub-id-type="pmid">23911327</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>del Toro</surname> <given-names>R</given-names></name><name><surname>Prahst</surname> <given-names>C</given-names></name><name><surname>Mathivet</surname> <given-names>T</given-names></name><name><surname>Siegfried</surname> <given-names>G</given-names></name><name><surname>Kaminker</surname> <given-names>JS</given-names></name><name><surname>Larrivee</surname> <given-names>B</given-names></name><name><surname>Breant</surname> <given-names>C</given-names></name><name><surname>Duarte</surname> <given-names>A</given-names></name><name><surname>Takakura</surname> <given-names>N</given-names></name><name><surname>Fukamizu</surname> <given-names>A</given-names></name><name><surname>Penninger</surname> <given-names>J</given-names></name><name><surname>Eichmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Identification and functional analysis of endothelial tip cell-enriched genes</article-title><source>Blood</source><volume>116</volume><fpage>4025</fpage><lpage>4033</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-02-270819</pub-id><pub-id pub-id-type="pmid">20705756</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobrina</surname> <given-names>A</given-names></name><name><surname>Rossi</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Metabolic properties of freshly isolated bovine endothelial cells</article-title><source>Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research</source><volume>762</volume><fpage>295</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/0167-4889(83)90084-8</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dray</surname> <given-names>C</given-names></name><name><surname>Knauf</surname> <given-names>C</given-names></name><name><surname>Daviaud</surname> <given-names>D</given-names></name><name><surname>Waget</surname> <given-names>A</given-names></name><name><surname>Boucher</surname> <given-names>J</given-names></name><name><surname>BulÃ©on</surname> <given-names>M</given-names></name><name><surname>Cani</surname> <given-names>PD</given-names></name><name><surname>AttanÃ©</surname> <given-names>C</given-names></name><name><surname>GuignÃ©</surname> <given-names>C</given-names></name><name><surname>CarpÃ©nÃ©</surname> <given-names>C</given-names></name><name><surname>Burcelin</surname> <given-names>R</given-names></name><name><surname>Castan-Laurell</surname> <given-names>I</given-names></name><name><surname>Valet</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Apelin stimulates glucose utilization in normal and obese insulin-resistant mice</article-title><source>Cell Metabolism</source><volume>8</volume><fpage>437</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2008.10.003</pub-id><pub-id pub-id-type="pmid">19046574</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname> <given-names>N</given-names></name><name><surname>Gerber</surname> <given-names>HP</given-names></name><name><surname>LeCouter</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The biology of VEGF and its receptors</article-title><source>Nature Medicine</source><volume>9</volume><fpage>669</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1038/nm0603-669</pub-id><pub-id pub-id-type="pmid">12778165</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerhardt</surname> <given-names>H</given-names></name><name><surname>Golding</surname> <given-names>M</given-names></name><name><surname>Fruttiger</surname> <given-names>M</given-names></name><name><surname>Ruhrberg</surname> <given-names>C</given-names></name><name><surname>Lundkvist</surname> <given-names>A</given-names></name><name><surname>Abramsson</surname> <given-names>A</given-names></name><name><surname>Jeltsch</surname> <given-names>M</given-names></name><name><surname>Mitchell</surname> <given-names>C</given-names></name><name><surname>Alitalo</surname> <given-names>K</given-names></name><name><surname>Shima</surname> <given-names>D</given-names></name><name><surname>Betsholtz</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia</article-title><source>Journal of Cell Biology</source><volume>161</volume><fpage>1163</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1083/jcb.200302047</pub-id><pub-id pub-id-type="pmid">12810700</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goetze</surname> <given-names>JP</given-names></name><name><surname>Rehfeld</surname> <given-names>JF</given-names></name><name><surname>Carlsen</surname> <given-names>J</given-names></name><name><surname>Videbaek</surname> <given-names>R</given-names></name><name><surname>Andersen</surname> <given-names>CB</given-names></name><name><surname>Boesgaard</surname> <given-names>S</given-names></name><name><surname>Friis-Hansen</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Apelin: a new plasma marker of cardiopulmonary disease</article-title><source>Regulatory Peptides</source><volume>133</volume><fpage>134</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.regpep.2005.09.032</pub-id><pub-id pub-id-type="pmid">16263185</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habata</surname> <given-names>Y</given-names></name><name><surname>Fujii</surname> <given-names>R</given-names></name><name><surname>Hosoya</surname> <given-names>M</given-names></name><name><surname>Fukusumi</surname> <given-names>S</given-names></name><name><surname>Kawamata</surname> <given-names>Y</given-names></name><name><surname>Hinuma</surname> <given-names>S</given-names></name><name><surname>Kitada</surname> <given-names>C</given-names></name><name><surname>Nishizawa</surname> <given-names>N</given-names></name><name><surname>Murosaki</surname> <given-names>S</given-names></name><name><surname>Kurokawa</surname> <given-names>T</given-names></name><name><surname>Onda</surname> <given-names>H</given-names></name><name><surname>Tatemoto</surname> <given-names>K</given-names></name><name><surname>Fujino</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum</article-title><source>Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research</source><volume>1452</volume><fpage>25</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/S0167-4889(99)00114-7</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamm</surname> <given-names>MJ</given-names></name><name><surname>Kirchmaier</surname> <given-names>BC</given-names></name><name><surname>Herzog</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sema3d controls collective endothelial cell migration by distinct mechanisms via Nrp1 and PlxnD1</article-title><source>Journal of Cell Biology</source><volume>215</volume><fpage>415</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1083/jcb.201603100</pub-id><pub-id pub-id-type="pmid">27799363</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasan</surname> <given-names>SS</given-names></name><name><surname>Tsaryk</surname> <given-names>R</given-names></name><name><surname>Lange</surname> <given-names>M</given-names></name><name><surname>Wisniewski</surname> <given-names>L</given-names></name><name><surname>Moore</surname> <given-names>JC</given-names></name><name><surname>Lawson</surname> <given-names>ND</given-names></name><name><surname>Wojciechowska</surname> <given-names>K</given-names></name><name><surname>Schnittler</surname> <given-names>H</given-names></name><name><surname>Siekmann</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Endothelial notch signalling limits angiogenesis via control of artery formation</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>928</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1038/ncb3574</pub-id><pub-id pub-id-type="pmid">28714969</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname> <given-names>T</given-names></name><name><surname>Kihara</surname> <given-names>M</given-names></name><name><surname>Imai</surname> <given-names>N</given-names></name><name><surname>Yoshida</surname> <given-names>S</given-names></name><name><surname>Shimoyamada</surname> <given-names>H</given-names></name><name><surname>Yasuzaki</surname> <given-names>H</given-names></name><name><surname>Ishida</surname> <given-names>J</given-names></name><name><surname>Toya</surname> <given-names>Y</given-names></name><name><surname>Kiuchi</surname> <given-names>Y</given-names></name><name><surname>Hirawa</surname> <given-names>N</given-names></name><name><surname>Tamura</surname> <given-names>K</given-names></name><name><surname>Yazawa</surname> <given-names>T</given-names></name><name><surname>Kitamura</surname> <given-names>H</given-names></name><name><surname>Fukamizu</surname> <given-names>A</given-names></name><name><surname>Umemura</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis</article-title><source>The American Journal of Pathology</source><volume>171</volume><fpage>1705</fpage><lpage>1712</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2007.070471</pub-id><pub-id pub-id-type="pmid">17884970</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helker</surname> <given-names>CS</given-names></name><name><surname>Schuermann</surname> <given-names>A</given-names></name><name><surname>Karpanen</surname> <given-names>T</given-names></name><name><surname>Zeuschner</surname> <given-names>D</given-names></name><name><surname>Belting</surname> <given-names>HG</given-names></name><name><surname>Affolter</surname> <given-names>M</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name><name><surname>Herzog</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The zebrafish common cardinal veins develop by a novel mechanism: lumen ensheathment</article-title><source>Development</source><volume>140</volume><fpage>2776</fpage><lpage>2786</lpage><pub-id pub-id-type="doi">10.1242/dev.091876</pub-id><pub-id pub-id-type="pmid">23698350</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helker</surname> <given-names>CSM</given-names></name><name><surname>Schuermann</surname> <given-names>A</given-names></name><name><surname>Pollmann</surname> <given-names>C</given-names></name><name><surname>Chng</surname> <given-names>SC</given-names></name><name><surname>Kiefer</surname> <given-names>F</given-names></name><name><surname>Reversade</surname> <given-names>B</given-names></name><name><surname>Herzog</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The hormonal peptide elabela guides angioblasts to the midline during vasculogenesis</article-title><source>eLife</source><volume>4</volume><elocation-id>e06726</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.06726</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helker</surname> <given-names>CSM</given-names></name><name><surname>Mullapudi</surname> <given-names>ST</given-names></name><name><surname>Mueller</surname> <given-names>LM</given-names></name><name><surname>Preussner</surname> <given-names>J</given-names></name><name><surname>Tunaru</surname> <given-names>S</given-names></name><name><surname>Skog</surname> <given-names>O</given-names></name><name><surname>Kwon</surname> <given-names>HB</given-names></name><name><surname>Kreuder</surname> <given-names>F</given-names></name><name><surname>Lancman</surname> <given-names>JJ</given-names></name><name><surname>Bonnavion</surname> <given-names>R</given-names></name><name><surname>Dong</surname> <given-names>PDS</given-names></name><name><surname>Looso</surname> <given-names>M</given-names></name><name><surname>Offermanns</surname> <given-names>S</given-names></name><name><surname>Korsgren</surname> <given-names>O</given-names></name><name><surname>Spagnoli</surname> <given-names>FM</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A whole organism small molecule screen identifies novel regulators of pancreatic endocrine development</article-title><source>Development</source><volume>146</volume><elocation-id>dev172569</elocation-id><pub-id pub-id-type="doi">10.1242/dev.172569</pub-id><pub-id pub-id-type="pmid">31142539</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>HellstrÃ¶m</surname> <given-names>M</given-names></name><name><surname>Phng</surname> <given-names>LK</given-names></name><name><surname>Hofmann</surname> <given-names>JJ</given-names></name><name><surname>Wallgard</surname> <given-names>E</given-names></name><name><surname>Coultas</surname> <given-names>L</given-names></name><name><surname>Lindblom</surname> <given-names>P</given-names></name><name><surname>Alva</surname> <given-names>J</given-names></name><name><surname>Nilsson</surname> <given-names>AK</given-names></name><name><surname>Karlsson</surname> <given-names>L</given-names></name><name><surname>Gaiano</surname> <given-names>N</given-names></name><name><surname>Yoon</surname> <given-names>K</given-names></name><name><surname>Rossant</surname> <given-names>J</given-names></name><name><surname>Iruela-Arispe</surname> <given-names>ML</given-names></name><name><surname>KalÃ©n</surname> <given-names>M</given-names></name><name><surname>Gerhardt</surname> <given-names>H</given-names></name><name><surname>Betsholtz</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis</article-title><source>Nature</source><volume>445</volume><fpage>776</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.1038/nature05571</pub-id><pub-id pub-id-type="pmid">17259973</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbert</surname> <given-names>SP</given-names></name><name><surname>Cheung</surname> <given-names>JY</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Determination of endothelial stalk versus tip cell potential during angiogenesis by H2.0-like homeobox-1</article-title><source>Current Biology</source><volume>22</volume><fpage>1789</fpage><lpage>1794</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2012.07.037</pub-id><pub-id pub-id-type="pmid">22921365</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname> <given-names>BM</given-names></name><name><surname>Herpers</surname> <given-names>R</given-names></name><name><surname>Witte</surname> <given-names>M</given-names></name><name><surname>HeloterÃ¤</surname> <given-names>H</given-names></name><name><surname>Alitalo</surname> <given-names>K</given-names></name><name><surname>Duckers</surname> <given-names>HJ</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries</article-title><source>Development</source><volume>136</volume><fpage>4001</fpage><lpage>4009</lpage><pub-id pub-id-type="doi">10.1242/dev.039990</pub-id><pub-id pub-id-type="pmid">19906867</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwangbo</surname> <given-names>C</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Papangeli</surname> <given-names>I</given-names></name><name><surname>Adachi</surname> <given-names>T</given-names></name><name><surname>Sharma</surname> <given-names>B</given-names></name><name><surname>Park</surname> <given-names>S</given-names></name><name><surname>Zhao</surname> <given-names>L</given-names></name><name><surname>Ju</surname> <given-names>H</given-names></name><name><surname>Go</surname> <given-names>GW</given-names></name><name><surname>Cui</surname> <given-names>G</given-names></name><name><surname>Inayathullah</surname> <given-names>M</given-names></name><name><surname>Job</surname> <given-names>JK</given-names></name><name><surname>Rajadas</surname> <given-names>J</given-names></name><name><surname>Kwei</surname> <given-names>SL</given-names></name><name><surname>Li</surname> <given-names>MO</given-names></name><name><surname>Morrison</surname> <given-names>AR</given-names></name><name><surname>Quertermous</surname> <given-names>T</given-names></name><name><surname>Mani</surname> <given-names>A</given-names></name><name><surname>Red-Horse</surname> <given-names>K</given-names></name><name><surname>Chun</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects</article-title><source>Science Translational Medicine</source><volume>9</volume><elocation-id>eaad4000</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aad4000</pub-id><pub-id pub-id-type="pmid">28904225</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobsson</surname> <given-names>L</given-names></name><name><surname>Franco</surname> <given-names>CA</given-names></name><name><surname>Bentley</surname> <given-names>K</given-names></name><name><surname>Collins</surname> <given-names>RT</given-names></name><name><surname>Ponsioen</surname> <given-names>B</given-names></name><name><surname>Aspalter</surname> <given-names>IM</given-names></name><name><surname>Rosewell</surname> <given-names>I</given-names></name><name><surname>Busse</surname> <given-names>M</given-names></name><name><surname>Thurston</surname> <given-names>G</given-names></name><name><surname>Medvinsky</surname> <given-names>A</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name><name><surname>Gerhardt</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting</article-title><source>Nature Cell Biology</source><volume>12</volume><fpage>943</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1038/ncb2103</pub-id><pub-id pub-id-type="pmid">20871601</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>KÃ¤lin</surname> <given-names>RE</given-names></name><name><surname>Kretz</surname> <given-names>MP</given-names></name><name><surname>Meyer</surname> <given-names>AM</given-names></name><name><surname>Kispert</surname> <given-names>A</given-names></name><name><surname>Heppner</surname> <given-names>FL</given-names></name><name><surname>BrÃ¤ndli</surname> <given-names>AW</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis</article-title><source>Developmental Biology</source><volume>305</volume><fpage>599</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2007.03.004</pub-id><pub-id pub-id-type="pmid">17412318</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidoya</surname> <given-names>H</given-names></name><name><surname>Ueno</surname> <given-names>M</given-names></name><name><surname>Yamada</surname> <given-names>Y</given-names></name><name><surname>Mochizuki</surname> <given-names>N</given-names></name><name><surname>Nakata</surname> <given-names>M</given-names></name><name><surname>Yano</surname> <given-names>T</given-names></name><name><surname>Fujii</surname> <given-names>R</given-names></name><name><surname>Takakura</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis</article-title><source>The EMBO Journal</source><volume>27</volume><fpage>522</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601982</pub-id><pub-id pub-id-type="pmid">18200044</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidoya</surname> <given-names>H</given-names></name><name><surname>Naito</surname> <given-names>H</given-names></name><name><surname>Takakura</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia</article-title><source>Blood</source><volume>115</volume><fpage>3166</fpage><lpage>3174</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-07-232306</pub-id><pub-id pub-id-type="pmid">20185589</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidoya</surname> <given-names>H</given-names></name><name><surname>Kunii</surname> <given-names>N</given-names></name><name><surname>Naito</surname> <given-names>H</given-names></name><name><surname>Muramatsu</surname> <given-names>F</given-names></name><name><surname>Okamoto</surname> <given-names>Y</given-names></name><name><surname>Nakayama</surname> <given-names>T</given-names></name><name><surname>Takakura</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy</article-title><source>Oncogene</source><volume>31</volume><fpage>3254</fpage><lpage>3264</lpage><pub-id pub-id-type="doi">10.1038/onc.2011.489</pub-id><pub-id pub-id-type="pmid">22037214</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidoya</surname> <given-names>H</given-names></name><name><surname>Naito</surname> <given-names>H</given-names></name><name><surname>Muramatsu</surname> <given-names>F</given-names></name><name><surname>Yamakawa</surname> <given-names>D</given-names></name><name><surname>Jia</surname> <given-names>W</given-names></name><name><surname>Ikawa</surname> <given-names>M</given-names></name><name><surname>Sonobe</surname> <given-names>T</given-names></name><name><surname>Tsuchimochi</surname> <given-names>H</given-names></name><name><surname>Shirai</surname> <given-names>M</given-names></name><name><surname>Adams</surname> <given-names>RH</given-names></name><name><surname>Fukamizu</surname> <given-names>A</given-names></name><name><surname>Takakura</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>APJ regulates parallel alignment of arteries and veins in the skin</article-title><source>Developmental Cell</source><volume>33</volume><fpage>247</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.02.024</pub-id><pub-id pub-id-type="pmid">25920569</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmel</surname> <given-names>CB</given-names></name><name><surname>Ballard</surname> <given-names>WW</given-names></name><name><surname>Kimmel</surname> <given-names>SR</given-names></name><name><surname>Ullmann</surname> <given-names>B</given-names></name><name><surname>Schilling</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Stages of embryonic development of the zebrafish</article-title><source>Developmental Dynamics</source><volume>203</volume><fpage>253</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1002/aja.1002030302</pub-id><pub-id pub-id-type="pmid">8589427</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname> <given-names>S</given-names></name><name><surname>Claesson-Welsh</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Signal transduction by vascular endothelial growth factor receptors</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>2</volume><elocation-id>a006502</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a006502</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname> <given-names>Y</given-names></name><name><surname>Kundu</surname> <given-names>RK</given-names></name><name><surname>Cox</surname> <given-names>CM</given-names></name><name><surname>Leeper</surname> <given-names>NJ</given-names></name><name><surname>Anderson</surname> <given-names>JA</given-names></name><name><surname>Chun</surname> <given-names>HJ</given-names></name><name><surname>Ali</surname> <given-names>ZA</given-names></name><name><surname>Ashley</surname> <given-names>EA</given-names></name><name><surname>Krieg</surname> <given-names>PA</given-names></name><name><surname>Quertermous</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Upregulation of the apelin-APJ pathway promotes neointima formation in the carotid ligation model in mouse</article-title><source>Cardiovascular Research</source><volume>87</volume><fpage>156</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvq052</pub-id><pub-id pub-id-type="pmid">20176814</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>KrÃ¼tzfeldt</surname> <given-names>A</given-names></name><name><surname>Spahr</surname> <given-names>R</given-names></name><name><surname>Mertens</surname> <given-names>S</given-names></name><name><surname>Siegmund</surname> <given-names>B</given-names></name><name><surname>Piper</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Metabolism of exogenous substrates by coronary endothelial cells in culture</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>22</volume><fpage>1393</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1016/0022-2828(90)90984-A</pub-id><pub-id pub-id-type="pmid">2089157</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname> <given-names>HB</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Helker</surname> <given-names>CS</given-names></name><name><surname>Rasouli</surname> <given-names>SJ</given-names></name><name><surname>Maischein</surname> <given-names>HM</given-names></name><name><surname>Offermanns</surname> <given-names>S</given-names></name><name><surname>Herzog</surname> <given-names>W</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In vivo modulation of endothelial polarization by apelin receptor signalling</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11805</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11805</pub-id><pub-id pub-id-type="pmid">27248505</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname> <given-names>ND</given-names></name><name><surname>Weinstein</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>In vivo imaging of embryonic vascular development using transgenic zebrafish</article-title><source>Developmental Biology</source><volume>248</volume><fpage>307</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1006/dbio.2002.0711</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname> <given-names>JD</given-names></name><name><surname>Ariza-McNaughton</surname> <given-names>L</given-names></name><name><surname>Bermange</surname> <given-names>AL</given-names></name><name><surname>McAdow</surname> <given-names>R</given-names></name><name><surname>Johnson</surname> <given-names>SL</given-names></name><name><surname>Lewis</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Endothelial signalling by the notch ligand Delta-like 4 restricts angiogenesis</article-title><source>Development</source><volume>134</volume><fpage>839</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1242/dev.003244</pub-id><pub-id pub-id-type="pmid">17251261</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobov</surname> <given-names>IB</given-names></name><name><surname>Renard</surname> <given-names>RA</given-names></name><name><surname>Papadopoulos</surname> <given-names>N</given-names></name><name><surname>Gale</surname> <given-names>NW</given-names></name><name><surname>Thurston</surname> <given-names>G</given-names></name><name><surname>Yancopoulos</surname> <given-names>GD</given-names></name><name><surname>Wiegand</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting</article-title><source>PNAS</source><volume>104</volume><fpage>3219</fpage><lpage>3224</lpage><pub-id pub-id-type="doi">10.1073/pnas.0611206104</pub-id><pub-id pub-id-type="pmid">17296940</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masri</surname> <given-names>B</given-names></name><name><surname>Morin</surname> <given-names>N</given-names></name><name><surname>Cornu</surname> <given-names>M</given-names></name><name><surname>Knibiehler</surname> <given-names>B</given-names></name><name><surname>Audigier</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells</article-title><source>The FASEB Journal</source><volume>18</volume><fpage>1909</fpage><lpage>1911</lpage><pub-id pub-id-type="doi">10.1096/fj.04-1930fje</pub-id><pub-id pub-id-type="pmid">15385434</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mertens</surname> <given-names>S</given-names></name><name><surname>Noll</surname> <given-names>T</given-names></name><name><surname>Spahr</surname> <given-names>R</given-names></name><name><surname>Krutzfeldt</surname> <given-names>A</given-names></name><name><surname>Piper</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Energetic response of coronary endothelial cells to hypoxia</article-title><source>American Journal of Physiology-Heart and Circulatory Physiology</source><volume>258</volume><fpage>H689</fpage><lpage>H694</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.1990.258.3.H689</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moepps</surname> <given-names>B</given-names></name><name><surname>Frodl</surname> <given-names>R</given-names></name><name><surname>Rodewald</surname> <given-names>HR</given-names></name><name><surname>Baggiolini</surname> <given-names>M</given-names></name><name><surname>Gierschik</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Two murine homologues of the human chemokine receptor CXCR4 mediating stromal cell-derived factor 1alpha activation of Gi2 are differentially expressed in vivo</article-title><source>European Journal of Immunology</source><volume>27</volume><fpage>2102</fpage><lpage>2112</lpage><pub-id pub-id-type="doi">10.1002/eji.1830270839</pub-id><pub-id pub-id-type="pmid">9295051</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papangeli</surname> <given-names>I</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Maier</surname> <given-names>I</given-names></name><name><surname>Park</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>A</given-names></name><name><surname>Kang</surname> <given-names>Y</given-names></name><name><surname>Tanaka</surname> <given-names>K</given-names></name><name><surname>Khan</surname> <given-names>OF</given-names></name><name><surname>Ju</surname> <given-names>H</given-names></name><name><surname>Kojima</surname> <given-names>Y</given-names></name><name><surname>Red-Horse</surname> <given-names>K</given-names></name><name><surname>Anderson</surname> <given-names>DG</given-names></name><name><surname>Siekmann</surname> <given-names>AF</given-names></name><name><surname>Chun</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MicroRNA 139-5p coordinates APLNR-CXCR4 crosstalk during vascular maturation</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11268</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11268</pub-id><pub-id pub-id-type="pmid">27068353</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauli</surname> <given-names>A</given-names></name><name><surname>Norris</surname> <given-names>ML</given-names></name><name><surname>Valen</surname> <given-names>E</given-names></name><name><surname>Chew</surname> <given-names>GL</given-names></name><name><surname>Gagnon</surname> <given-names>JA</given-names></name><name><surname>Zimmerman</surname> <given-names>S</given-names></name><name><surname>Mitchell</surname> <given-names>A</given-names></name><name><surname>Ma</surname> <given-names>J</given-names></name><name><surname>Dubrulle</surname> <given-names>J</given-names></name><name><surname>Reyon</surname> <given-names>D</given-names></name><name><surname>Tsai</surname> <given-names>SQ</given-names></name><name><surname>Joung</surname> <given-names>JK</given-names></name><name><surname>Saghatelian</surname> <given-names>A</given-names></name><name><surname>Schier</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Toddler: an embryonic signal that promotes cell movement via apelin receptors</article-title><source>Science</source><volume>343</volume><elocation-id>1248636</elocation-id><pub-id pub-id-type="doi">10.1126/science.1248636</pub-id><pub-id pub-id-type="pmid">24407481</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phng</surname> <given-names>L-K</given-names></name><name><surname>Stanchi</surname> <given-names>F</given-names></name><name><surname>Gerhardt</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Filopodia are dispensable for endothelial tip cell guidance</article-title><source>Development</source><volume>140</volume><fpage>4031</fpage><lpage>4040</lpage><pub-id pub-id-type="doi">10.1242/dev.097352</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitkin</surname> <given-names>SL</given-names></name><name><surname>Maguire</surname> <given-names>JJ</given-names></name><name><surname>Kuc</surname> <given-names>RE</given-names></name><name><surname>Davenport</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Modulation of the apelin/APJ system in heart failure and atherosclerosis in man</article-title><source>British Journal of Pharmacology</source><volume>160</volume><fpage>1785</fpage><lpage>1795</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2010.00821.x</pub-id><pub-id pub-id-type="pmid">20649580</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitulescu</surname> <given-names>ME</given-names></name><name><surname>Schmidt</surname> <given-names>I</given-names></name><name><surname>Giaimo</surname> <given-names>BD</given-names></name><name><surname>Antoine</surname> <given-names>T</given-names></name><name><surname>Berkenfeld</surname> <given-names>F</given-names></name><name><surname>Ferrante</surname> <given-names>F</given-names></name><name><surname>Park</surname> <given-names>H</given-names></name><name><surname>Ehling</surname> <given-names>M</given-names></name><name><surname>Biljes</surname> <given-names>D</given-names></name><name><surname>Rocha</surname> <given-names>SF</given-names></name><name><surname>Langen</surname> <given-names>UH</given-names></name><name><surname>Stehling</surname> <given-names>M</given-names></name><name><surname>Nagasawa</surname> <given-names>T</given-names></name><name><surname>Ferrara</surname> <given-names>N</given-names></name><name><surname>Borggrefe</surname> <given-names>T</given-names></name><name><surname>Adams</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dll4 and notch signalling couples sprouting angiogenesis and artery formation</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>915</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1038/ncb3555</pub-id><pub-id pub-id-type="pmid">28714968</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roman</surname> <given-names>BL</given-names></name><name><surname>Pham</surname> <given-names>VN</given-names></name><name><surname>Lawson</surname> <given-names>ND</given-names></name><name><surname>Kulik</surname> <given-names>M</given-names></name><name><surname>Childs</surname> <given-names>S</given-names></name><name><surname>Lekven</surname> <given-names>AC</given-names></name><name><surname>Garrity</surname> <given-names>DM</given-names></name><name><surname>Moon</surname> <given-names>RT</given-names></name><name><surname>Fishman</surname> <given-names>MC</given-names></name><name><surname>Lechleider</surname> <given-names>RJ</given-names></name><name><surname>Weinstein</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>'Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels'</article-title><source>Development</source><volume>129</volume><fpage>3009</fpage><lpage>3019</lpage><pub-id pub-id-type="pmid">12050147</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawane</surname> <given-names>M</given-names></name><name><surname>Kajiya</surname> <given-names>K</given-names></name><name><surname>Kidoya</surname> <given-names>H</given-names></name><name><surname>Takagi</surname> <given-names>M</given-names></name><name><surname>Muramatsu</surname> <given-names>F</given-names></name><name><surname>Takakura</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity</article-title><source>Diabetes</source><volume>62</volume><fpage>1970</fpage><lpage>1980</lpage><pub-id pub-id-type="doi">10.2337/db12-0604</pub-id><pub-id pub-id-type="pmid">23378608</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlereth</surname> <given-names>K</given-names></name><name><surname>Weichenhan</surname> <given-names>D</given-names></name><name><surname>Bauer</surname> <given-names>T</given-names></name><name><surname>Heumann</surname> <given-names>T</given-names></name><name><surname>Giannakouri</surname> <given-names>E</given-names></name><name><surname>Lipka</surname> <given-names>D</given-names></name><name><surname>Jaeger</surname> <given-names>S</given-names></name><name><surname>Schlesner</surname> <given-names>M</given-names></name><name><surname>Aloy</surname> <given-names>P</given-names></name><name><surname>Eils</surname> <given-names>R</given-names></name><name><surname>Plass</surname> <given-names>C</given-names></name><name><surname>Augustin</surname> <given-names>HG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium</article-title><source>eLife</source><volume>7</volume><elocation-id>e34423</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.34423</pub-id><pub-id pub-id-type="pmid">29749927</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname> <given-names>H</given-names></name><name><surname>Chivite</surname> <given-names>I</given-names></name><name><surname>Angulo-Urarte</surname> <given-names>A</given-names></name><name><surname>Soler</surname> <given-names>A</given-names></name><name><surname>Sutherland</surname> <given-names>JD</given-names></name><name><surname>Arruabarrena-Aristorena</surname> <given-names>A</given-names></name><name><surname>Ragab</surname> <given-names>A</given-names></name><name><surname>Lim</surname> <given-names>R</given-names></name><name><surname>Malumbres</surname> <given-names>M</given-names></name><name><surname>Fruttiger</surname> <given-names>M</given-names></name><name><surname>Potente</surname> <given-names>M</given-names></name><name><surname>Serrano</surname> <given-names>M</given-names></name><name><surname>Fabra</surname> <given-names>Ã</given-names></name><name><surname>ViÃ±als</surname> <given-names>F</given-names></name><name><surname>Casanovas</surname> <given-names>O</given-names></name><name><surname>Pandolfi</surname> <given-names>PP</given-names></name><name><surname>Bigas</surname> <given-names>A</given-names></name><name><surname>Carracedo</surname> <given-names>A</given-names></name><name><surname>Gerhardt</surname> <given-names>H</given-names></name><name><surname>Graupera</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PTEN mediates Notch-dependent stalk cell arrest in angiogenesis</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7935</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8935</pub-id><pub-id pub-id-type="pmid">26228240</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siekmann</surname> <given-names>AF</given-names></name><name><surname>Lawson</surname> <given-names>ND</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries</article-title><source>Nature</source><volume>445</volume><fpage>781</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1038/nature05577</pub-id><pub-id pub-id-type="pmid">17259972</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suchting</surname> <given-names>S</given-names></name><name><surname>Freitas</surname> <given-names>C</given-names></name><name><surname>le Noble</surname> <given-names>F</given-names></name><name><surname>Benedito</surname> <given-names>R</given-names></name><name><surname>BrÃ©ant</surname> <given-names>C</given-names></name><name><surname>Duarte</surname> <given-names>A</given-names></name><name><surname>Eichmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching</article-title><source>PNAS</source><volume>104</volume><fpage>3225</fpage><lpage>3230</lpage><pub-id pub-id-type="doi">10.1073/pnas.0611177104</pub-id><pub-id pub-id-type="pmid">17296941</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szokodi</surname> <given-names>I</given-names></name><name><surname>Tavi</surname> <given-names>P</given-names></name><name><surname>FÃ¶ldes</surname> <given-names>G</given-names></name><name><surname>Voutilainen-MyllylÃ¤</surname> <given-names>S</given-names></name><name><surname>Ilves</surname> <given-names>M</given-names></name><name><surname>Tokola</surname> <given-names>H</given-names></name><name><surname>Pikkarainen</surname> <given-names>S</given-names></name><name><surname>Piuhola</surname> <given-names>J</given-names></name><name><surname>RysÃ¤</surname> <given-names>J</given-names></name><name><surname>TÃ³th</surname> <given-names>M</given-names></name><name><surname>Ruskoaho</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility</article-title><source>Circulation Research</source><volume>91</volume><fpage>434</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1161/01.res.0000033522.37861.69</pub-id><pub-id pub-id-type="pmid">12215493</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tammela</surname> <given-names>T</given-names></name><name><surname>Zarkada</surname> <given-names>G</given-names></name><name><surname>Wallgard</surname> <given-names>E</given-names></name><name><surname>MurtomÃ¤ki</surname> <given-names>A</given-names></name><name><surname>Suchting</surname> <given-names>S</given-names></name><name><surname>Wirzenius</surname> <given-names>M</given-names></name><name><surname>Waltari</surname> <given-names>M</given-names></name><name><surname>HellstrÃ¶m</surname> <given-names>M</given-names></name><name><surname>Schomber</surname> <given-names>T</given-names></name><name><surname>Peltonen</surname> <given-names>R</given-names></name><name><surname>Freitas</surname> <given-names>C</given-names></name><name><surname>Duarte</surname> <given-names>A</given-names></name><name><surname>Isoniemi</surname> <given-names>H</given-names></name><name><surname>Laakkonen</surname> <given-names>P</given-names></name><name><surname>Christofori</surname> <given-names>G</given-names></name><name><surname>YlÃ¤-Herttuala</surname> <given-names>S</given-names></name><name><surname>Shibuya</surname> <given-names>M</given-names></name><name><surname>Pytowski</surname> <given-names>B</given-names></name><name><surname>Eichmann</surname> <given-names>A</given-names></name><name><surname>Betsholtz</surname> <given-names>C</given-names></name><name><surname>Alitalo</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation</article-title><source>Nature</source><volume>454</volume><fpage>656</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1038/nature07083</pub-id><pub-id pub-id-type="pmid">18594512</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatemoto</surname> <given-names>K</given-names></name><name><surname>Hosoya</surname> <given-names>M</given-names></name><name><surname>Habata</surname> <given-names>Y</given-names></name><name><surname>Fujii</surname> <given-names>R</given-names></name><name><surname>Kakegawa</surname> <given-names>T</given-names></name><name><surname>Zou</surname> <given-names>MX</given-names></name><name><surname>Kawamata</surname> <given-names>Y</given-names></name><name><surname>Fukusumi</surname> <given-names>S</given-names></name><name><surname>Hinuma</surname> <given-names>S</given-names></name><name><surname>Kitada</surname> <given-names>C</given-names></name><name><surname>Kurokawa</surname> <given-names>T</given-names></name><name><surname>Onda</surname> <given-names>H</given-names></name><name><surname>Fujino</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor</article-title><source>Biochemical and Biophysical Research Communications</source><volume>251</volume><fpage>471</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1998.9489</pub-id><pub-id pub-id-type="pmid">9792798</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tempel</surname> <given-names>D</given-names></name><name><surname>de Boer</surname> <given-names>M</given-names></name><name><surname>van Deel</surname> <given-names>ED</given-names></name><name><surname>Haasdijk</surname> <given-names>RA</given-names></name><name><surname>Duncker</surname> <given-names>DJ</given-names></name><name><surname>Cheng</surname> <given-names>C</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name><name><surname>Duckers</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Apelin enhances cardiac neovascularization after myocardial infarction by recruiting aplnr+ circulating cells</article-title><source>Circulation Research</source><volume>111</volume><fpage>585</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.262097</pub-id><pub-id pub-id-type="pmid">22753078</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High-resolution in situ hybridization to whole-mount zebrafish embryos</article-title><source>Nature Protocols</source><volume>3</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.514</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres-VÃ¡zquez</surname> <given-names>J</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name><name><surname>Fraser</surname> <given-names>SD</given-names></name><name><surname>Berk</surname> <given-names>JD</given-names></name><name><surname>Pham</surname> <given-names>VN</given-names></name><name><surname>Fishman</surname> <given-names>MC</given-names></name><name><surname>Childs</surname> <given-names>S</given-names></name><name><surname>Epstein</surname> <given-names>JA</given-names></name><name><surname>Weinstein</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Semaphorin-plexin signaling guides patterning of the developing vasculature</article-title><source>Developmental Cell</source><volume>7</volume><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2004.06.008</pub-id><pub-id pub-id-type="pmid">15239959</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uribesalgo</surname> <given-names>I</given-names></name><name><surname>Hoffmann</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Kavirayani</surname> <given-names>A</given-names></name><name><surname>Lazovic</surname> <given-names>J</given-names></name><name><surname>Berta</surname> <given-names>J</given-names></name><name><surname>Novatchkova</surname> <given-names>M</given-names></name><name><surname>Pai</surname> <given-names>TP</given-names></name><name><surname>Wimmer</surname> <given-names>RA</given-names></name><name><surname>LÃ¡szlÃ³</surname> <given-names>V</given-names></name><name><surname>Schramek</surname> <given-names>D</given-names></name><name><surname>Karim</surname> <given-names>R</given-names></name><name><surname>Tortola</surname> <given-names>L</given-names></name><name><surname>Deswal</surname> <given-names>S</given-names></name><name><surname>Haas</surname> <given-names>L</given-names></name><name><surname>Zuber</surname> <given-names>J</given-names></name><name><surname>SzÅ±cs</surname> <given-names>M</given-names></name><name><surname>Kuba</surname> <given-names>K</given-names></name><name><surname>Dome</surname> <given-names>B</given-names></name><name><surname>Cao</surname> <given-names>Y</given-names></name><name><surname>Haubner</surname> <given-names>BJ</given-names></name><name><surname>Penninger</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy</article-title><source>EMBO Molecular Medicine</source><volume>11</volume><elocation-id>e9266</elocation-id><pub-id pub-id-type="doi">10.15252/emmm.201809266</pub-id><pub-id pub-id-type="pmid">31267692</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandekeere</surname> <given-names>S</given-names></name><name><surname>Dewerchin</surname> <given-names>M</given-names></name><name><surname>Carmeliet</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Angiogenesis revisited: an overlooked role of endothelial cell metabolism in vessel sprouting</article-title><source>Microcirculation</source><volume>22</volume><fpage>509</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1111/micc.12229</pub-id><pub-id pub-id-type="pmid">26250801</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanhollebeke</surname> <given-names>B</given-names></name><name><surname>Stone</surname> <given-names>OA</given-names></name><name><surname>Bostaille</surname> <given-names>N</given-names></name><name><surname>Cho</surname> <given-names>C</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Maquet</surname> <given-names>E</given-names></name><name><surname>Gauquier</surname> <given-names>A</given-names></name><name><surname>Cabochette</surname> <given-names>P</given-names></name><name><surname>Fukuhara</surname> <given-names>S</given-names></name><name><surname>Mochizuki</surname> <given-names>N</given-names></name><name><surname>Nathans</surname> <given-names>J</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Tip cell-specific requirement for an atypical Gpr124- and Reck-dependent wnt/Î²-catenin pathway during brain angiogenesis</article-title><source>eLife</source><volume>4</volume><elocation-id>e06489</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.06489</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villefranc</surname> <given-names>JA</given-names></name><name><surname>Amigo</surname> <given-names>J</given-names></name><name><surname>Lawson</surname> <given-names>ND</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Gateway compatible vectors for analysis of gene function in the zebrafish</article-title><source>Developmental Dynamics</source><volume>236</volume><fpage>3077</fpage><lpage>3087</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21354</pub-id><pub-id pub-id-type="pmid">17948311</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>McKinnie</surname> <given-names>SM</given-names></name><name><surname>Patel</surname> <given-names>VB</given-names></name><name><surname>Haddad</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Zhabyeyev</surname> <given-names>P</given-names></name><name><surname>Das</surname> <given-names>SK</given-names></name><name><surname>Basu</surname> <given-names>R</given-names></name><name><surname>McLean</surname> <given-names>B</given-names></name><name><surname>Kandalam</surname> <given-names>V</given-names></name><name><surname>Penninger</surname> <given-names>JM</given-names></name><name><surname>Kassiri</surname> <given-names>Z</given-names></name><name><surname>Vederas</surname> <given-names>JC</given-names></name><name><surname>Murray</surname> <given-names>AG</given-names></name><name><surname>Oudit</surname> <given-names>GY</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Loss of apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic apelin analogues</article-title><source>Journal of the American Heart Association</source><volume>2</volume><elocation-id>e000249</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.113.000249</pub-id><pub-id pub-id-type="pmid">23817469</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiley</surname> <given-names>DM</given-names></name><name><surname>Kim</surname> <given-names>JD</given-names></name><name><surname>Hao</surname> <given-names>J</given-names></name><name><surname>Hong</surname> <given-names>CC</given-names></name><name><surname>Bautch</surname> <given-names>VL</given-names></name><name><surname>Jin</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Distinct signalling pathways regulate sprouting angiogenesis from the dorsal aorta and the axial vein</article-title><source>Nature Cell Biology</source><volume>13</volume><fpage>686</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1038/ncb2232</pub-id><pub-id pub-id-type="pmid">21572418</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname> <given-names>K</given-names></name><name><surname>Happel</surname> <given-names>K</given-names></name><name><surname>Eelen</surname> <given-names>G</given-names></name><name><surname>Schoors</surname> <given-names>S</given-names></name><name><surname>Oellerich</surname> <given-names>MF</given-names></name><name><surname>Lim</surname> <given-names>R</given-names></name><name><surname>Zimmermann</surname> <given-names>B</given-names></name><name><surname>Aspalter</surname> <given-names>IM</given-names></name><name><surname>Franco</surname> <given-names>CA</given-names></name><name><surname>Boettger</surname> <given-names>T</given-names></name><name><surname>Braun</surname> <given-names>T</given-names></name><name><surname>Fruttiger</surname> <given-names>M</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name><name><surname>Keller</surname> <given-names>C</given-names></name><name><surname>BrÃ¼ning</surname> <given-names>JC</given-names></name><name><surname>Gerhardt</surname> <given-names>H</given-names></name><name><surname>Carmeliet</surname> <given-names>P</given-names></name><name><surname>Potente</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>FOXO1 couples metabolic activity and growth state in the vascular endothelium</article-title><source>Nature</source><volume>529</volume><fpage>216</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1038/nature16498</pub-id><pub-id pub-id-type="pmid">26735015</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Feng</surname> <given-names>F</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Apelin-13 protects against myocardialÂ infarction-induced myocardial fibrosis</article-title><source>Molecular Medicine Reports</source><volume>13</volume><fpage>5262</fpage><lpage>5268</lpage><pub-id pub-id-type="doi">10.3892/mmr.2016.5163</pub-id><pub-id pub-id-type="pmid">27109054</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Tian</surname> <given-names>X</given-names></name><name><surname>He</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Pu</surname> <given-names>W</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Tang</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Cheng</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Zhou</surname> <given-names>Q</given-names></name><name><surname>Tan</surname> <given-names>Z</given-names></name><name><surname>Bai</surname> <given-names>F</given-names></name><name><surname>Xu</surname> <given-names>F</given-names></name><name><surname>Smart</surname> <given-names>N</given-names></name><name><surname>Zhou</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Apj<sup>+</sup>vessels drive tumor growth and represent a tractable therapeutic target</article-title><source>Cell Reports</source><volume>25</volume><fpage>1241</fpage><lpage>1254</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.10.015</pub-id><pub-id pub-id-type="pmid">30380415</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.55589.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Burns</surname><given-names>Caroline E</given-names></name><role>Reviewing Editor</role><aff><institution>Boston Children's Hospital</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Mochizuki</surname><given-names>Naoki</given-names> </name><role>Reviewer</role><aff><institution>National Cerebral and Cardiovascular Center Research Institute</institution><country>Japan</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The finding that Apelin signaling alters metabolism to drive angiogenesis downstream of the Notch pathway is interesting and novel. The most impressive additions that were made during the revision period to substantiate the author's claims include new panels at 30 hpf showing <italic>apln:EGFP</italic> is more prominent in the tips cells than in the stalk, the increase of filopodia and endothelial cell numbers in apln mutants that show excessive sprouting, suppression of the hyper-sprouting phenotype in dll morphants by <italic>aplnrb</italic> loss-of-function, and <italic>pfkfb3</italic> endothelial cell (EC)-specific overexpression that increases EC metabolic activity rescues sprouting in <italic>aplnrb</italic> mutants. While the conclusions could have been better substantiated by the additional experiments proposed by the reviewers (specifically the experiments that address the link between metabolism and ISV sprouting), the revision is reasonable.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Apelin signaling drives vascular endothelial cells towards a pro-angiogenic state&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Naoki Mochizuki (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The manuscript &quot;Apelin signaling drives vascular endothelial cells towards a pro-angiogenic state&quot; by Helker et al. uses genetic approaches in zebrafish embryos to provide new insights into the regulation of vessel growth by apelin signaling. Specifically, they address expression of Apelin and the Apelin receptor and their functional roles in sprouting intersomitic vessels (ISVs) in the embryonic trunk using new transgenic reporters, existing genetic mutants, and mosaic analyses. Furthermore, they show that Apelin signaling is required for the hypersprouting phenotype resulting from compromised Notch function. A final set of data links Apelin to endothelial cell metabolism.</p><p>Essential revisions:</p><p>1) The claim that apelin is expressed in tip cells is not well supported by the data provided. It appears that <italic>apln</italic>:<italic>EGFP</italic> staining at 26 hpf is very prominent outside the vasculature (presumably, notochord and spinal cord), which makes it difficult to appreciate the fluorescent signal in tip cells (Figure 1A). The authors should clarify whether <italic>apln</italic> expression is found outside the vasculature and provide clearer images of tip cell expression. In addition, it is important to know whether the sprouts shown on the far left in A' are composed of a single (tip) cell or multiple cells. In case of the latter, it is not obvious that tips are positive whereas stalk cells are not.</p><p>2) The cellular mechanism underlying the observed ISV sprouting defect in apelin mutants is not well-defined. Specifically, does apelin primarily regulate filopodia or endothelial cell numbers to alter ISV sprouting? Is it known that tip cell filapodia number correlate with sprout length/distance? If so, do Notch-deficient embryos that show excessive sprouting have increased numbers of tip cell filopodia? Does taking Apelin signaling away from dll morphant embryos decrease filapodia number? It is argued that the overexpression of <italic>apln</italic> does not lead to ectopic sprouting. Nevertheless, the images shown in Figure 2âfigure supplement 3 suggest that filopodia numbers, morphology, or extension might be altered. Please clarify.</p><p>3) There is an internal inconsistency regarding heightened Apelin expression must be rectified. The authors claim that heightened Apelin expression in Notch-deficient embryos is responsible for the observed hyperspouting phenotype. However, overexpression of Apelin in their hsp70:apelin transgenic line fails to show a hypersprouting phenotype. One possibility is that expression of the Apelin receptor is limiting. Is there a constitutively active apelin receptor that could be used to test whether the Apelin signaling axis is sufficient to promote angiogenesis? Can the hyper-sprouting phenotype observed in Notch-deficient embryos also be suppressed by loss of the Apelin receptor? (Dll4 morpholino into <italic>alpnr-/-</italic> embryos)? Experimental clarification of the model is needed.</p><p>4) The link between Apelin and Notch is interesting, but it is unclear whether this effect is mediated by VEGF or increased hypoxia, which were previously linked to the regulation of <italic>apln</italic> expression. The authors should try to clarify the link between Notch and Apelin.</p><p>5) The claim that Apelin drives angiogenesis by increasing endothelial cell glycolysis/metabolism is not well supported. Specifically, the connection between <italic>apln</italic> and metabolic alterations has been only explored in cultured cells in vitro and its relevance for the observed phenotypes in zebrafish remains unclear. The authors should validate their key findings in vivo and explore how apelin regulates the metabolic properties of ECs. For example, could 2-DG be used to inhibit glycolysis in zebrafish embryos and ISV sprouting examined? Is glycolysis/metabolism increased in Notch-inhibited vessels that show hypersprouting? Can this phenotype be suppressed by 2-DG? Is there a method to artificially increase metabolism in order to learn whether this is sufficient to promote ISV sprouting? If so, does it rescue sprouting in apelin mutants?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.55589.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The claim that apelin is expressed in tip cells is not well supported by the data provided. It appears that apln:EGFP staining at 26 hpf is very prominent outside the vasculature (presumably, notochord and spinal cord), which makes it difficult to appreciate the fluorescent signal in tip cells (Figure 1A). The authors should clarify whether apln expression is found outside the vasculature and provide clearer images of tip cell expression. In addition, it is important to know whether the sprouts shown on the far left in A' are composed of a single (tip) cell or multiple cells. In case of the latter, it is not obvious that tips are positive whereas stalk cells are not.</p></disp-quote><p><italic>apln</italic> expression is enriched in tip cells but is not exclusive to these cells. <italic>apln</italic> expression is also observed in the notochord around 17 hpf (Helker et al., 2015) as well as in the neural tube, and due to the stability of the GFP protein, these tissues are still GFP positive at 26 hpf. Therefore, the EC specific signal is much more visible at 54 hpf when GFP in the notochord and neural tube has mostly been degraded. In Figure 1Aââ, the arrowheads point to strong <italic>apln</italic> expression in tip cells, while the arrows point to weak <italic>apln</italic> expression in stalk cells. We added these points in the Results section as well as in the figure legend. In addition, we replaced picture 1Aâ with a new one at 30 hpf â a time point when <italic>apln</italic> expression is a bit stronger and easier to visualize.</p><disp-quote content-type="editor-comment"><p>2) The cellular mechanism underlying the observed ISV sprouting defect in apelin mutants is not well-defined. Specifically, does apelin primarily regulate filopodia or endothelial cell numbers to alter ISV sprouting? Is it known that tip cell filapodia number correlate with sprout length/distance?</p></disp-quote><p>Phng et al. reported that the inhibition of filopodia formation by Latrunculin B treatment reduces ISV sprout length (See Figure 5C from Phng et al., 2013), consistent with our hypothesis that the ISV sprouting defects in <italic>apln</italic> mutants are caused by the filopodia defects. However, one cannot exclude the possibility that defects in EC numbers are also contributing to the ISV sprouting defects. These points are now included in the Discussion.</p><disp-quote content-type="editor-comment"><p>If so, do Notch-deficient embryos that show excessive sprouting have increased numbers of tip cell filopodia?</p></disp-quote><p>Several studies have reported that inhibition of Notch signaling increases filopodia numbers (Hellstrom et al., 2007; Leslie et al., 2007; Siekmann et al., 2007; Suchting et al., 2007).</p><disp-quote content-type="editor-comment"><p>Does taking Apelin signaling away from dll morphant embryos decrease filapodia number?</p></disp-quote><p>Phng et al. reported that ectopic sprouting in <italic>dll4</italic> morphants occurs in the absence of filopodia (Phng et al., 2013). Therefore, it is unlikely that the reduction of filopodia observed in <italic>apln/aplnrb</italic> mutants is the reason for the rescue of the hypersprouting phenotype in <italic>apln</italic> or <italic>aplnrb</italic> mutants injected with the <italic>dll4</italic> morpholino.</p><disp-quote content-type="editor-comment"><p>It is argued that the overexpression of apln does not lead to ectopic sprouting. Nevertheless, the images shown in Figure 2âfigure supplement 3 suggest that filopodia numbers, morphology, or extension might be altered. Please clarify.</p></disp-quote><p>We thank the reviewers for this valid point. Indeed, overexpression of <italic>apln</italic> leads to defects in lymphatic endothelial cell sprouting. We labeled these defects in Figure 2âfigure supplement 3 using arrows and added this additional point to the Results section.</p><disp-quote content-type="editor-comment"><p>3) There is an internal inconsistency regarding heightened Apelin expression must be rectified. The authors claim that heightened Apelin expression in Notch-deficient embryos is responsible for the observed hyperspouting phenotype. However, overexpression of Apelin in their hsp70:apelin transgenic line fails to show a hypersprouting phenotype. One possibility is that expression of the Apelin receptor is limiting. Is there a constitutively active apelin receptor that could be used to test whether the Apelin signaling axis is sufficient to promote angiogenesis? Can the hyper-sprouting phenotype observed in Notch-deficient embryos also be suppressed by loss of the Apelin receptor? (Dll4 morpholino into alpnr-/- embryos)? Experimental clarification of the model is needed.</p></disp-quote><p>We are thankful for these comments and questions. The Apelin receptor is a GPCR and to the best of our knowledge there is no constitutively active form of it available to date. However, we injected the <italic>dll4</italic> morpholino into <italic>aplnrb</italic> mutant embryos, and found that the hypersprouting phenotype observed in Notch-deficient embryos was also suppressed by the loss of the Apelin receptor. These new data can be found in supplemental Figure 4âfigure supplement 1.</p><disp-quote content-type="editor-comment"><p>4) The link between Apelin and Notch is interesting, but it is unclear whether this effect is mediated by VEGF or increased hypoxia, which were previously linked to the regulation of apln expression. The authors should try to clarify the link between Notch and Apelin.</p></disp-quote><p>The transcriptional regulation of Apelin Signaling components by Notch signaling is very interesting. However, it is very unlikely that <italic>apln</italic> is a direct Notch target gene since activation of Notch signaling leads to a downregulation of <italic>APLN</italic> expression. Therefore, we speculate that <italic>apln</italic> expression is regulated by downstream Notch target genes such as those encoding members of the HES/HEY Transcription factor family, which are known to act as transcriptional repressors. This point has now been included in the Discussion. Thus, further work is required to obtain a detailed view of the regulation of Apelin signaling components by Notch signaling.</p><disp-quote content-type="editor-comment"><p>5) The claim that Apelin drives angiogenesis by increasing endothelial cell glycolysis/metabolism is not well supported. Specifically, the connection between apln and metabolic alterations has been only explored in cultured cells in vitro and its relevance for the observed phenotypes in zebrafish remains unclear. The authors should validate their key findings in vivo and explore how apelin regulates the metabolic properties of ECs. For example, could 2-DG be used to inhibit glycolysis in zebrafish embryos and ISV sprouting examined? Is glycolysis/metabolism increased in Notch-inhibited vessels that show hypersprouting? Can this phenotype be suppressed by 2-DG? Is there a method to artificially increase metabolism in order to learn whether this is sufficient to promote ISV sprouting? If so, does it rescue sprouting in apelin mutants?</p></disp-quote><p>It has been shown that stimulation of Apelin signaling induces the phosphorylation, and therefore nuclear exclusion, of FOXO1 (Figure 3B from Hwangbo et al., 2017). Furthermore, expression of a constitutively active FOXO1, which remains in the nucleus, has been shown to reduce MYC protein levels (Figure 3K from Wilhelm et al., 2016), and reduce metabolic activity (Figure 3E from Wilhelm et al., 2016). In agreement with these in vitro data, deleting <italic>Foxo1</italic> in mouse ECs enhances metabolic activity and promotes EC sprouting in vivo (Figure 1B/C from Wilhelm et al., 2016).</p><p>Since 2-DG treatments not only affect ECs but the whole organism, we overexpressed <italic>pfkfb3</italic> specifically in ECs in the <italic>aplnrb</italic> mutant background. These experiments show that enhancing the metabolic activity of ECs can rescue the sprouting phenotype of <italic>aplnrb</italic> mutant embryos. These new data can be found in Figure 5.</p></body></sub-article></article>